UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q

 

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended March 31, 2024

 

OR

 

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from __________ to __________.

 

Commission File Number: 033-33263

 

Jacksam Corporation

(Exact name of registrant as specified in its charter)

 

Nevada

46-3566284

(State or other jurisdiction of

incorporation or organization)

(IRS Employer

Identification No.)

3100 Airway Avenue Suite 138

Costa Mesa, CA

92626

(Address of principal executive offices)

(Zip Code)

 

Registrant’s telephone number, including area code: (800) 605-3580

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of Each Class

 

Trading Symbol

 

Name of Each Exchange on Which Registered

Common Stock, par value $0.001 per share

 

JKSM

 

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒     No ☐

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒     No ☐

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer

Accelerated filer

Non-accelerated filer

Smaller reporting company

Emerging Growth Company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes      No ☒

 

As of May 15, 2024, the registrant had 94,663,320 shares of common stock, $0.001 par value per share, outstanding.

 

 

 

 

TABLE OF CONTENTS

 

 

Page

 

 

PART I — FINANCIAL INFORMATION

 

 

Item 1.

Unaudited Financial Statements

 

 

 

 

 

 

 

 

Condensed Consolidated Balance Sheets

 

4

 

Condensed Consolidated Statements of Operations and Comprehensive Loss

 

5

 

 

Condensed Consolidated Statements of Stockholders’ Deficit

 

6

 

 

Condensed Consolidated Statements of Cash Flows

 

7

 

Notes to Condensed Consolidated Financial Statements

 

8

 

 

 

 

 

Item 2.

Management’s Discussion and Analysis of Financial Condition and Results of Operations

21

 

 

Item 3.

Quantitative and Qualitative Disclosures About Market Risk

23

 

 

Item 4.

Controls and Procedures

23

 

 

PART II — OTHER INFORMATION

 

 

Item 1.

Legal Proceedings

24

 

 

Item 1A.

Risk Factors

24

 

 

Item 2.

Unregistered Sales of Equity Securities and Use of Proceeds

24

 

 

Item 3.

Defaults Upon Senior Securities

24

 

 

Item 4.

Mine Safety Disclosures

24

 

 

 

Item 5.

Other Information

24

 

 

Item 6.

Exhibits

25

 

 

 

Signatures

 

 

26

 

 
2

Table of Contents

  

Forward-Looking Statements

 

For purposes of this report, unless otherwise indicated or the context otherwise requires, all references herein to “Jacksam Corporation”, “the Company”, “we”, “us”, and “our”, refer to Jacksam Corporation, a Nevada corporation.

 

This Quarterly Report on Form 10-Q, or this Report, contains forward-looking statements. Any and all statements contained in this Report that are not statements of historical fact may be deemed forward-looking statements. Terms such as “may”, “might”, “would”, “should”, “could”, “project”, “estimate”, “pro-forma”, “predict”, “potential”, “strategy”, “anticipate”, “attempt”, “develop”, “plan”, “help”, “believe”, “continue”, “intend”, “expect”, “future” and terms of similar import (including the negative of any of the foregoing) may be intended to identify forward-looking statements. However, not all forward-looking statements may contain one or more of these identifying terms. Forward-looking statements in this Report may include, without limitation, statements regarding (i) the plans and objectives of management for future operations, including plans or objectives relating to the development of our cartridge filling machines, cartridge capping machines and cartridges, (ii) a projection of income (including income/loss), earnings (including earnings/loss) per share, capital expenditures, dividends, capital structure or other financial items, (iii) our future financial performance, including any such statement contained in a discussion and analysis of financial condition by management or in the results of operations included pursuant to the rules and regulations of the Securities and Exchange Commission, or the SEC, and (iv) the assumptions underlying or relating to any statement described in points (i), (ii) or (iii) above.

 

The forward-looking statements are not meant to predict or guarantee actual results, performance, events or circumstances and may not be realized because they are based upon our current projections, plans, objectives, beliefs, expectations, estimates and assumptions and are subject to a number of risks and uncertainties and other influences, many of which we have no control over. Actual results and the timing of certain events and circumstances may differ materially from those described by the forward-looking statements as a result of these risks and uncertainties.

 

 
3

Table of Contents

 

Jacksam Corporation

Condensed Consolidated Balance Sheets

(Unaudited)

 

 

 

 

 

 

 

March 31,

 

 

December 31,

 

 

 

2024

 

 

2023

 

Assets

 

 

 

 

 

 

 

Current Assets:

 

 

 

 

 

 

Cash

 

$104,425

 

 

$145,521

 

Accounts receivable, net

 

 

18,115

 

 

 

9,515

 

Inventory, net

 

 

-

 

 

 

-

 

Prepaid expenses

 

 

-

 

 

 

77,625

 

Total Current Assets

 

 

122,540

 

 

 

232,661

 

 

 

 

 

 

 

 

 

 

Property and equipment, net

 

 

32

 

 

 

128

 

Right of-use asset - operating lease

 

 

34,991

 

 

 

43,965

 

 

 

 

 

 

 

 

 

 

Total Assets

 

$157,563

 

 

$276,754

 

 

 

 

 

 

 

 

 

 

Liabilities and Stockholders’ Deficit

 

 

 

 

 

 

 

 

 

Current Liabilities:

 

 

 

 

 

 

 

 

Accounts payable and accrued expenses

 

$717,359

 

 

$756,456

 

Accrued dividends

 

 

89,972

 

 

 

160,000

 

Deferred revenue

 

 

826,321

 

 

 

902,485

 

Convertible notes payable, current portion

 

 

1,148,278

 

 

 

444,444

 

Notes payable, current portion

 

 

613,551

 

 

 

619,932

 

Line of Credit

 

 

50,000

 

 

 

50,000

 

Right of use liability - operating lease, current portion

 

 

41,524

 

 

 

39,255

 

Derivative liability

 

 

-

 

 

 

-

 

Accrued liabilities - other

 

 

1,642,269

 

 

 

1,642,269

 

Subscription payable

 

 

499,999

 

 

 

499,999

 

Total Current Liabilities

 

 

5,629,273

 

 

 

5,114,840

 

 

 

 

 

 

 

 

 

 

Notes payable, net of current portion (net of discount $87,385 and $94,095 respectively)

 

 

137,100

 

 

 

137,972

 

Right of use liability - operating lease

 

 

-

 

 

 

6,978

 

Total Liabilities

 

 

5,766,373

 

 

 

5,259,790

 

 

 

 

 

 

 

 

 

 

Commitment

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Mezzanine equity

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Series A Preferred stock - 2,800,000 authorized, $0.001 par value, 2,800,000 and 0 shares issued and outstanding as of March 31, 2024 and December 31, 2023

 

 

287,763

 

 

 

284,622

 

 

 

 

 

 

 

 

 

 

Stockholders' Deficit:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Preferred stock - 30,000,000 authorized, $0.001 par value, 0 shares issued and outstanding

 

 

-

 

 

 

-

 

Series B Preferred Stock - 1,000,000 authorized, $0.001 par value, $1 stated value, 1,000,000 and 0 shares issued and outstanding as of March 31, 2024 and December 31, 2023, respectively

 

 

50

 

 

 

100

 

Common stock - 200,000,000 authorized, $0.001 par value, 94,663,320 and 81,088,719 shares issued and outstanding as of March 31, 2024 and December 31, 2023, respectively

 

 

94,662

 

 

 

81,088

 

Additional paid-in capital

 

 

8,467,090

 

 

 

8,562,630

 

Accumulated deficit

 

 

(14,458,375)

 

 

(13,911,476)

Total Stockholders' Deficit

 

 

(5,896,573)

 

 

(5,267,658)

 

 

 

 

 

 

 

 

 

Total Liabilities and Stockholders' Deficit

 

$157,563

 

 

$276,754

 

 

 

 

 

 

 

 

 

 

The accompanying notes are an integral part of these unaudited consolidated financial statements

 

 
4

Table of Contents

    

Jacksam Corporation

Condensed Consolidated Statements of Operations

For the Three Months Ended March 31, 2024 and 2023

(Unaudited)

 

 

 

 

 

March 31, 2024

 

 

March 31, 2023

 

 

 

 

 

 

 

 

Sales

 

$295,333

 

 

$628,425

 

 

 

 

 

 

 

 

 

 

Cost of sales

 

 

196,189

 

 

 

405,312

 

 

 

 

 

 

 

 

 

 

Gross profit

 

 

99,144

 

 

 

223,113

 

 

 

 

 

 

 

 

 

 

Operating expenses

 

 

 

 

 

 

 

 

Salaries and wages (including contractors)

 

 

46,968

 

 

 

112,887

 

Other selling, general and administrative expenses

 

 

516,964

 

 

 

130,736

 

Total operating expenses

 

 

563,932

 

 

 

243,623

 

 

 

 

 

 

 

 

 

 

Income (loss) from operations

 

 

(464,788)

 

 

(20,510)

 

 

 

 

 

 

 

 

 

Other income (expense)

 

 

 

 

 

 

 

 

Derivative gain (loss)

 

 

-

 

 

 

123,301

 

Interest expense

 

 

(82,111)

 

 

(47,362)

Loss on conversion of notes payable

 

 

-

 

 

 

-

 

Gain on settlement of notes payable

 

 

-

 

 

 

-

 

Total other income (expense)

 

 

(82,111)

 

 

75,939

 

 

 

 

 

 

 

 

 

 

Net income (loss)

 

 

(546,899)

 

 

55,429

 

 

 

 

 

 

 

 

 

 

Deemed dividend on preferred exchange

 

 

(83,836)

 

 

-

 

Preferred stock dividends

 

 

(13,114)

 

 

(22,833)

 

 

 

 

 

 

 

 

 

Net income (loss) available to common shareholders

 

$(643,849)

 

$32,596

 

 

 

 

 

 

 

 

 

 

Net loss per share

 

 

 

 

 

 

 

 

Basic

 

$(0.01)

 

$0.00

 

Diluted

 

$(0.01)

 

$(0.00)

 

 

 

 

 

 

 

 

 

Weighted average shares outstanding

 

 

 

 

 

 

 

 

Basic

 

 

93,465,344

 

 

 

81,088,719

 

Diluted

 

 

93,465,344

 

 

 

173,229,460

 

 

The accompanying notes are an integral part of these unaudited consolidated financial statements

 

 
5

Table of Contents

  

Jacksam Corporation

Condensed Consolidated Statements of Stockholders' Deficit

For the Three Months Ended March 31, 2024 and 2023

(Unaudited)

  

 

 

Series A Preferred Stock,

 

 

Series B Preferred Stock,

 

 

Common Stock, $0.001 Par Value

 

 

 Paid-In

 

 

Share

 

 

 Accumulated

 

 

 Stockholders'

 

 

 

 Shares

 

 

Amount

 

 

 Shares

 

 

Amount

 

 

 Shares

 

 

Amount

 

 

 Capital

 

 

 Payable

 

 

 Deficit

 

 

 Deficit

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance, December 31, 2022

 

 

2,800,000

 

 

 

272,022

 

 

 

1,000,000

 

 

 

100

 

 

 

81,088,719

 

 

 

81,088

 

 

 

7,451,916

 

 

 

-

 

 

 

(12,652,285)

 

 

(5,119,181)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Dividends on Series A and B Preferred Stock

 

 

-

 

 

 

3,107

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(22,833)

 

 

-

 

 

 

-

 

 

 

(22,833)

Net income

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

55,429

 

 

 

55,429

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance, March 31, 2023

 

 

2,800,000

 

 

$275,129

 

 

 

1,000,000

 

 

$100

 

 

 

81,088,719

 

 

$81,088

 

 

$7,429,083

 

 

$-

 

 

$(12,596,856)

 

$(5,086,585)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance, December 31, 2023

 

 

2,800,000

 

 

$284,622

 

 

 

1,000,000

 

 

$100

 

 

 

81,088,719

 

 

$81,088

 

 

$8,562,630

 

 

$-

 

 

$(13,911,476)

 

$(5,267,658)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Shares issued for compensation

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

9,888,888

 

 

 

9,888

 

 

 

421,020

 

 

 

 

 

 

 

 

 

 

 

430,908

 

Shares issued for exercise of warrants

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

685,713

 

 

 

686

 

 

 

6,171

 

 

 

 

 

 

 

 

 

 

 

6,857

 

Common shares issued and conversion of Preferred B shares in connection with Note payable

 

 

 

 

 

 

 

 

 

 

(500,000)

 

$(50)

 

 

3,000,000

 

 

 

3,000

 

 

 

(425,781)

 

 

 

 

 

 

 

 

 

 

(422,831)

Deemed dividend on extinguishment of Preferred B

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(83,836)

 

 

 

 

 

 

 

 

 

 

(83,836)

Dividends on Series A and B Preferred Stock

 

 

-

 

 

 

3,141

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(13,114)

 

 

-

 

 

 

-

 

 

 

(13,114)

Net loss

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(546,899)

 

 

(546,899)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance, March 31, 2024

 

 

2,800,000

 

 

$287,763

 

 

 

500,000

 

 

$50

 

 

 

94,663,320

 

 

$94,662

 

 

$8,467,090

 

 

$-

 

 

$(14,458,375)

 

$(5,896,573)

 

The accompanying notes are an integral part of these unaudited consolidated financial statements

 

 
6

Table of Contents

 

Jacksam Corporation

Condensed Consolidated Statements of Cash Flows

For the Three Months Ended March 31, 2024 and 2023

(Unaudited)

  

 

 

March 31, 2024

 

 

March 31, 2023

 

Cash Flows from Operating Activities

 

 

 

 

 

 

Net income (loss)

 

$(546,899)

 

$55,429

 

Adjustments to reconcile net income (loss) to net cash used in operating activities:

 

 

 

 

 

 

 

 

Depreciation expense

 

 

96

 

 

 

96

 

Amortization of debt discount

 

 

17,167

 

 

 

7,711

 

Amortization of right-of-use assets

 

 

8,974

 

 

 

8,113

 

Derivative (gain) loss

 

 

-

 

 

 

(123,301)

Net change in:

 

 

 

 

 

 

 

 

Accounts receivable

 

 

(8,600)

 

 

(673)

Inventory

 

 

-

 

 

 

(24,635)

Prepaid expenses

 

 

77,625

 

 

 

4,560

 

Right-of-use liabilities

 

 

(4,709)

 

 

(7,992)

Accounts payable and accrued expenses

 

 

(39,098)

 

 

20,931

 

Deferred revenue

 

 

(76,164)

 

 

(215,276)

 

 

 

 

 

 

 

 

 

Net cash used in operating activities

 

 

(133,843)

 

 

(275,037)

 

 

 

 

 

 

 

 

 

Cash Flows from Financing Activities

 

 

 

 

 

 

 

 

Proceeds from line of credit

 

 

-

 

 

 

50,000

 

Proceeds from convertible notes payable

 

 

100,000

 

 

 

-

 

Payment of debt issuance costs

 

 

-

 

 

 

(1,000)

Payments on notes payable

 

 

(7,253)

 

 

(62,022)

 

 

 

 

 

 

 

 

 

Net cash provided by (used in) financing activities

 

 

92,747

 

 

 

(13,022)

 

 

 

 

 

 

 

 

 

Net Change in Cash

 

 

(41,096)

 

 

(288,059)

 

 

 

 

 

 

 

 

 

Cash, Beginning of  Period

 

 

145,521

 

 

 

482,908

 

 

 

 

 

 

 

 

 

 

Cash, End of Period

 

$104,425

 

 

$194,849

 

 

 

 

 

 

 

 

 

 

Cash Paid For:

 

 

 

 

 

 

 

 

Income Taxes

 

$-

 

 

$-

 

Interest

 

$912

 

 

$5,946

 

 

 

 

 

 

 

 

 

 

Non-cash transactions:

 

 

 

 

 

 

 

 

Conversion of Preferred B and accrued dividends into convertible note payable

 

$580,000

 

 

$-

 

Deemed dividend on extinguishment of Preferred B

 

$83,836

 

 

$-

 

Preferred stock dividends

 

$13,114

 

 

$22,833

 

Exercise of warrants

 

$686

 

 

$-

 

 

The accompanying notes are an integral part of these unaudited consolidated financial statements

 

 
7

Table of Contents

 

Jacksam Corporation

Notes to Condensed Consolidated Financial Statements

 

Note 1: Organization and Nature of Operations

 

Jacksam Corporation dba Convectium is a technology company focused on developing and commercializing products of vaporizer cartridge filling & capping, pre-roll filling, and other automation systems. The Company’s product line primarily consisted of the 710 Shark cartridge filling machine, the 710 Captain cartridge capping machine, the “PreRoll-ER” pre-roll & cone filling machine, and cartridges. The Company’s customers are primarily businesses operating in jurisdictions that have some form of cannabis legalization. These businesses include medical and recreational dispensaries, large and small-scale processors and growers, multi-state operators, and distributors. The Company utilizes its direct sales force, website, strategic partners’ sales force, independent sales representatives, and a wide range of referral network to sell its products.

 

The Company was incorporated in the State of Nevada on September 21, 1989 under the name of Fulton Ventures, Inc. Since incorporated, the Company has engaged in a variety of businesses, but has been inactive since late 2014 through the Merger that closed on September 14, 2018. Since the Merger, the Company has been operated under the control of current management and continued to operate the business of Jacksam Corporation, described herein, as our sole business.

 

Note 2: Significant Accounting Policies

 

Basis of Preparation

 

The accompanying financial statements of the Company have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) under the accrual basis of accounting. These financial statements are presented in U.S. dollars and are prepared on a historical cost basis, except for certain financial instruments which are carried at fair value. The accompanying unaudited interim consolidated financial statements of the Company have been prepared in accordance with accounting principles generally accepted in the United States of America and should be read in conjunction with the audited consolidated financial statements and notes thereto for the years ended December 31, 2023 in the Form 10-K filed on April 16, 2024. In the opinion of management, all adjustments, consisting of normal recurring adjustments, necessary for a fair presentation of financial position and the results of operations for the interim periods presented have been reflected herein. The results of operations for the interim periods are not necessarily indicative of the results to be expected for the full year. Notes to the consolidated financial statements which would substantially duplicate the disclosures contained in the Form 10-K have been omitted.

 

Principles of Consolidation

 

The accompanying consolidated financial statements include the accounts of Jacksam Corporation and its wholly owned subsidiary. All intercompany transactions and balances are eliminated in consolidation.

 

Use of Estimates

 

The preparation of financial statements is in conformity with U.S. GAAP and requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Such estimates and assumptions impact both assets and liabilities, including but not limited to net realizable value of accounts receivable and inventory, estimated useful lives and potential impairment of property and equipment, estimate of fair value of share-based payments and derivative liabilities, estimates of fair value of warrants issued and recorded as debt discount and estimates of the probability and potential magnitude of contingent liabilities. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate could change in the near term due to one or more future nonconforming events. Accordingly, actual results could differ significantly from estimates.

 

 
8

Table of Contents

 

 

Risks and Uncertainties

 

The Company’s operations are subject to risk and uncertainties including financial, operational, regulatory and other risks including the potential risk of business failure. The Company has experienced, and in the future, expects to continue to experience, variability in its sales and earnings. The factors expected to contribute to this variability include, among others, (i) the uncertainty associated with the commercialization and ultimate success of the product, (ii) competition inherent at large national retail chains where product is expected to be sold, (iii) general economic conditions, and (iv) the related volatility of prices pertaining to the cost of sales.

 

Cash and Cash Equivalents

 

Cash and cash equivalents are carried at cost and consist of cash on hand and demand deposits placed with banks or other financial institutions, and all highly liquid investments with an original maturity of three months or less. Federal Deposit Insurance Corporation (“FDIC”) deposit insurance covers $250,000 per depositor, per FDIC-insured bank, per ownership category. The Company has no amounts in excess of the FDIC limit as of December 31, 2023

 

Accounts Receivable and Allowance for Doubtful Accounts

 

Accounts receivable are recorded at the invoiced amount and do not bear interest. The Company extends unsecured credit to its customers in the ordinary course of business but mitigates the associated risks by performing credit checks and actively pursuing past due accounts. The Company recognizes an allowance for losses on accounts receivable in an amount equal to the estimated probable losses net of recoveries. The allowance is based on an analysis of historical bad debt experience, current receivables aging, and expected future bad debts, as well as an assessment of specific identifiable customer accounts considered at risk or uncollectible. As of March 31, 2024 and December 31, 2023 and 2022, the Company had recorded an allowance for doubtful accounts of $264,659, respectively. The net accounts receivable at March 31, 2024 and December 31, 2023 were $18,815 and $9,515, respectively.

 

Inventory

 

Inventories are stated at the lower of cost, determined on the average cost basis, or net realizable value. Cost principally consists of the purchase price (adjusted for lower of cost or market), customs, duties, and freight. The Company periodically reviews historical sales activity to determine potentially obsolete items and evaluates the impact of any anticipated changes in future demand.

 

The March 31, 2024 and December 31, 2023 inventory consisted entirely of finished goods. The Company will maintain an allowance based on specific inventory items that have shown no activity over a 60-month period. The Company tracks inventory as it is disposed, scrapped or sold at below cost to determine whether additional items on hand should be reduced in value through an allowance method. As of March 31, 2024 and December 31, 2023, the Company’s inventory allowance was estimated at $244,658 and $244,658, respectively.

 

Property and Equipment

 

Property and equipment are measured at cost, less accumulated depreciation, and are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Depreciation of property and equipment is provided utilizing the straight-line method over the estimated useful lives, ranging from 5 to 7 years of the respective assets. Expenditures for maintenance and repairs are charged to expense as incurred. Upon sale or retirement of property and equipment, the related cost and accumulated depreciation are removed from the accounts and any gain or loss is reflected in the statements of operations.

 

Fair Value of Financial Instruments

 

The Company measures assets and liabilities at fair value based on an expected exit price as defined by the authoritative guidance on fair value measurements, which represents the amount that would be received on the sale of an asset or paid to transfer a liability, as the case may be, in an orderly transaction between market participants. As such, fair value may be based on assumptions that market participants would use in pricing an asset or liability. The authoritative guidance on fair value measurements establishes a consistent framework for measuring fair value on either a recurring or nonrecurring basis whereby inputs, used in valuation techniques, are assigned a hierarchical level.

 

 
9

Table of Contents

 

The following are the hierarchical levels of inputs to measure fair value:

 

·

Level 1 – Observable inputs that reflect quoted market prices in active markets for identical assets or liabilities.

 

 

·

Level 2 - Inputs reflect quoted prices for identical assets or liabilities in markets that are not active; Quoted prices for similar assets or liabilities in active markets; Inputs other than quoted prices that are observable for the assets or liabilities; or inputs that are derived principally from or corroborated by observable market data by correlation or other means.

 

 

·

Level 3 – Unobservable inputs reflecting the Company’s assumptions incorporated in valuation techniques used to determine fair value. These assumptions are required to be consistent with market participant assumptions that are reasonably available.

 

The carrying amounts of the Company’s financial assets and liabilities, such as cash, prepaid expenses, other current assets, accounts payable & accrued expenses, certain notes payable and deferred revenue are an approximate of their fair values because of the short maturity of these instruments. The Company’s derivative liabilities recognized at fair value on a recurring basis are a level 3 measurement. See Note 6.

 

Binomial Calculation Model

 

The Company uses a binomial calculator model to determine fair market value of derivative liabilities, warrants and options issued.

 

Preferred Stock Subject to Possible Redemption

 

The Company accounts for its preferred stock subject to possible redemption in accordance with the guidance in Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity”. Preferred stock subject to mandatory redemption (if any) are classified as a liability instrument and are measured at fair value. Conditionally redeemable preferred stock (including preferred stock that feature redemption rights that are either within the control of the holder or subject to the redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, preferred stock is classified as stockholders’ equity.

 

Revenue Recognition

 

The Company derives revenues from the sale of machines and non-machine products (customizable and C-Cell cartridges and accessories). The Company recognizes revenue in accordance with ASC 606. Revenues are recognized when control of the promised goods or services is transferred to the customer in an amount that reflects the consideration the Company expects to be entitled to in exchange for transferring those goods or services.

 

Revenue is recognized based on the following five step model:

 

 

-

Identification of the contract with a customer

 

-

Identification of the performance obligations in the contract

 

-

Determination of the transaction price

 

-

Allocation of the transaction price to the performance obligations in the contract

 

-

Recognition of revenue when, or as, the Company satisfies a performance obligation

 

 
10

Table of Contents

 

 

Performance Obligations

 

Sales of machines and non-machine products are recognized when all the following criteria are satisfied: (i) a contract with an end user exists which has commercial substance; (ii) it is probable the Company will collect the amount charged to the end user; and (iii) the Company has completed its performance obligation whereby the end user has obtained control of the product. A contract with commercial substance exists once the Company receives and accepts a purchase order or once it enters into a contract with an end user. If collectability is not probable, the sale is deferred and not recognized until collection is probable or payment is received. Control of products typically transfers when title and risk of ownership of the product has transferred to the customer. The customer has a 10-day period to inspect the equipment and may return the product if it does not meet the agreed-upon specifications. For contracts with multiple performance obligations, the Company allocates the total transaction price to each performance obligation in an amount based on the estimated relative standalone selling prices of the promised goods or services underlying each performance obligation. The Company uses an observable price to determine the stand-alone selling price for separate performance obligations or a cost plus margin approach when one is not available. Historically, the Company’s contracts have not had multiple performance obligations. The large majority of the Company’s performance obligations are recognized at a point in time related to the sale of machines and non-machine products.

 

Sales, value add, and other taxes collected concurrent with revenue-producing activities are excluded from revenue. Incidental items that are immaterial in the context of the contract are recognized as expense. Payment terms between invoicing and when payment is due is less than one year. As of March 31, 2024 and December 31, 2023, none of the Company’s contracts contained a significant financing component.

 

The Company elected the practical expedient to not adjust the amount of revenue to be recognized under a contract with an end user for the effects of time value of money when the timing difference between receipt of payment and recognition of revenue is less than one year.

 

The majority of the Company’s contracts offer an assurance-type warranty of the products at no additional cost for a period of 3 years. Assurance-type warranties provide a customer with assurance that the related product will function as the parties intended because it complies with agreed-upon specifications. Such warranties do not represent a separate performance obligation. At the time a sale is recognized, the Company estimated future warranty costs, which were trivial.

 

Transaction Price Allocated to the Remaining Performance Obligations

 

At a given point in time, the Company may have collected payment for future sales of product to begin production. These transactions are deferred until the product transfers to the customer and the performance obligation is considered complete. As of March 31, 2024, $826,321 in revenue is expected to be recognized in the future related to performance obligations that are unsatisfied (or partially unsatisfied) at the end of the reporting period. The Company expects to recognize all of our unsatisfied (or partially unsatisfied) performance obligations as revenue in the next twelve months.

 

Contract Costs

 

Costs incurred to obtain a customer contract are not material to the Company. The Company elected to apply the practical expedient to not capitalize contract costs to obtain contracts with a duration of one year or less, which are expensed and included within cost of goods and services.

 

Critical Accounting Estimates

 

Estimates are used to determine the amount of any variable consideration in contracts and the standalone selling price among separate performance obligations. The Company reviews and updates these estimates regularly.

 

 
11

Table of Contents

 

 

Disaggregation of Revenue

 

All machine sales and most non-machine sales are completed in North America.

 

 

 

Three Months Ended

March 31, 2024

 

 

Three Months Ended

March 31, 2023

 

Machine sales

 

$70,000

 

 

$343,000

 

Non-Machine sales

 

 

225,333

 

 

 

285,425

 

Total sales

 

$295,333

 

 

$628,425

 

 

Net Loss Per Common Share

 

Basic net loss per common share is computed by dividing net loss by the weighted-average number of common shares outstanding during the period. Potential common stock equivalents are determined using the treasury stock method. For diluted net loss per share purposes, the Company excludes stock options and other stock-based awards, including shares issued as a result of option exercises that are subject to repurchase by the Company, whose effect would be anti-dilutive from the calculation.

 

The following table presents the effect of potential dilutive issuances for the three months ended March 31, 2024 and 2023:

 

 

 

Three Months Ended

 

 

 

March 31,

2024

 

 

March 31,

2023

 

 

 

 

 

 

 

 

Net income (loss) attributable to common stockholders

 

$(643,849 )

 

$32,596

 

Preferred stock dividends

 

 

13,144

 

 

 

22,833

 

Derivative gain

 

 

-

 

 

 

(123,301 )

Deemed dividend on preferred exchange

 

 

83,836

 

 

 

-

 

Interest expense associated with convertible debt

 

 

80,773

 

 

 

-

 

Net income (loss) for dilutive calculation

 

 

(466,126 )

 

 

(67,872 )

 

 

 

 

 

 

 

 

 

Weighted average shares outstanding

 

 

93,465,344

 

 

 

8,108,819

 

Dilutive effect of preferred stock

 

 

9,733,333

 

 

 

18,066,667

 

Dilutive effect of convertible debt

 

 

119,977,814

 

 

 

74,074,074

 

Dilutive effect of common stock warrants

 

 

250,945

 

 

 

-

 

Weighted average shares outstanding for diluted net income (loss) per share

 

 

223,427,436

 

 

 

173,229,460

 

 

During the three months ended March 31, 2024, the impact of the 12,480,954 outstanding warrants to purchase common stock, 119,977,814 shares issuable under convertible debt and 9,733,333 shares issuable under convertible preferred stock were excluded from the calculation above as their impact would be anti-dilutive. The calculation for each period presented also excludes 2,777,778 shares not yet issued related to conversions of debt that occurred in 2020.

 

Income Tax Provision

 

The Company accounts for income taxes under Section 740-10-30 of the FASB Accounting Standards Codification, which requires recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the financial statements or tax returns. Under this method, deferred tax assets and liabilities are based on the differences between the financial statement and tax bases of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to reverse. Deferred tax assets are reduced by a valuation allowance to the extent management concludes it is more likely than not that the assets will not be realized. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in the Statements of Operations in the period that includes the enactment date.

 

 
12

Table of Contents

 

ASC 740 prescribes a comprehensive model for how companies should recognize, measure, present, and disclose in their financial statements uncertain tax positions taken or expected to be taken on a tax return. Under ASC 740, tax positions must initially be recognized in the financial statements when it is more likely than not the position will be sustained upon examination by the tax authorities. Such tax positions must initially and subsequently be measured as the largest amount of tax benefit that has a greater than 50% likelihood of being realized upon ultimate settlement with the tax authority assuming full knowledge of the position and relevant facts.

 

The Company recognizes interest and penalties related to unrecognized tax benefits within income tax expense. Accrued interest and penalties are included within the related tax liability.

 

Going Concern

 

The Company’s financial statements are prepared using U.S. GAAP to a going concern, which contemplates the realization of assets and liquidation of liabilities in the normal course of business. However, the Company has negative working capital, recurring losses, and does not have a source of revenues sufficient to cover its operating costs. These factors raise substantial doubt about the Company’s ability to continue as a going concern.

 

The ability of the Company to continue as a going concern is dependent upon its ability to successfully execute the business plan and attain profitable operations. The accompanying financial statements do not include any adjustments that may be necessary if the Company is unable to continue as a going concern.

 

In the coming year, the Company’s foreseeable cash requirements will relate to continual development of the operations of its business, maintaining its good standing and making the requisite filings with the SEC, and the payment of expenses associated with operations and business developments. The Company may experience a cash shortfall and be required to raise additional capital.

 

Historically, it has mostly relied upon convertible notes payable and cash flows from operations to finance its operations and growth. Management may raise additional capital by retaining net earnings or through future private offerings of the Company’s stock or through loans from private investors, although there can be no assurance that it will be able to obtain such financing. The Company’s failure to do so could have a material and adverse effect upon it and its shareholders.

 

Advertising and Marketing Expenses

 

The Company expenses the cost of advertising and promotions as incurred. Advertising and promotions expense was $0 and $220 for the three months ended March 31, 2024 and 2023, respectively.

 

Research and Development Costs

 

Research and development costs are expensed as incurred. The Company incurred no research and development costs during the three months ended March 31, 2024 and 2023.

 

Lease Arrangements

 

The Company follows the guidance of ASC 842 for accounting for leases. Transactions give rise to leases when the Company receives substantially all the economic benefits from and has the ability to direct the use of specified property and equipment. The Company determines if an arrangement is a lease at inception. The operating lease ROU assets are included within the Company’s non-current assets and lease liabilities are included in current or non-current liabilities on the Company’s consolidated balance sheets.

 

ROU assets represent the Company’s right to use, or control the use of, a specified asset for the lease term. Lease liabilities are the Company’s obligation to make lease payments arising from a lease and are measured on a discounted basis. Operating lease ROU assets and operating lease liabilities are recognized based on the present value of the future minimum lease payments over the lease term on the commencement date. The operating lease ROU asset includes any lease payments made and initial direct costs incurred and excludes lease incentives. The lease terms may include options to extend or terminate the lease when it is reasonably certain that the Company will exercise that option. Lease expense for minimum lease payments continues to be recognized on a straight-line basis over the lease term.

 

 
13

Table of Contents

 

 

Recently Issued Accounting Pronouncements

 

From time to time, new accounting pronouncements are issued by the Financial Accounting Standards Board (“FASB”) or other standard setting bodies that are adopted by the Company as of the specified effective date. Unless otherwise discussed, the Company believes that the effect of recently issued standards that are not yet effective and will not have a material effect on its consolidated financial position or results of operations upon adoption.

 

Note 3: Property and Equipment

 

Property and equipment consist of the following:

 

 

 

March 31,

2024

 

 

December 31,

2023

 

 

 

 

 

 

 

 

Furniture and fixtures

 

$10,425

 

 

$10,425

 

Equipment

 

 

7,579

 

 

 

7,579

 

Trade show display

 

 

2,640

 

 

 

2,640

 

Total

 

 

20,644

 

 

 

20,644

 

Less: Accumulated depreciation

 

 

(20,612 )

 

 

(20,516 )

Property and equipment, net

 

$32

 

 

$128

 

 

Depreciation expense amounted to $96 for the three months ended March 31, 2024 and 2023, respectively.

 

Note 4: Accounts Payable and Accrued Expenses

 

Accounts payable and accrued expenses consist of the following:

 

 

 

March 31,

2024

 

 

December 31,

2023

 

 

 

 

 

 

 

 

Accounts payable

 

$189,783

 

 

$292,912

 

Accrued interest

 

 

383,023

 

 

 

318,991

 

Sales tax payable

 

 

144,553

 

 

 

144,553

 

Total Accounts payable and Accrued expenses

 

$717,359

 

 

$756,456

 

 

Note 5: Notes Payable and Line of Credit

 

A summary of Notes Payable are as follows:

 

 

 

March 31,

2024

 

 

December 31,

2023

 

 

 

 

 

 

 

 

SBA loan May 2020

 

 

140,863

 

 

 

141,412

 

Note payable September 2021

 

 

609,788

 

 

 

616,492

 

 

 

 

 

 

 

 

 

 

Total notes payable

 

 

750,651

 

 

 

757,904

 

Less: discount and deferred finance costs

 

 

-

 

 

 

-

 

Less: current portion

 

 

(613,551 )

 

 

(619,932 )

Long-term portion of notes payable

 

$137,100

 

 

 

137,972

 

 

 
14

Table of Contents

 

 

On June 2, 2020, the Company received $150,000 under the Small Business Administration’s Economic Injury Disaster Loan. The loan bears interest at a fixed rate of 3.75%, and matures on May 26, 2050, payable monthly with payments of $731 beginning twelve months after issuance. The loan gives the Small Business Administration a security interest in all assets of the Company. As of March 31, 2024 and December 31, 2023, the Company owed a principal amount of $140,863 and $141,412 under this loan.

 

On September 29, 2021, the Company entered into a Revenue Loan and Security Agreement with an investor for up to a total amount of $1,000,000. Upon drawing from the facility and continuing thereafter until maturity or earlier prepayment in full, the Company shall pay monthly to the lender an amount equal to the product of (i) all revenue of the Company for the immediately preceding month multiplied by (ii) an applicable revenue percentage. On September 29, 2021, the Company borrowed $750,000 under the agreement and received initial cash proceeds of $727,500. The Company also paid an additional $5,000 in fees to the investor to secure the loan for total deferred financing fees of $27,500. On November 12, 2021, the Company issued a total of 843,750 shares of common stock to a lender in connection with the note payable issued. These shares had a fair value of $100,744 and were recorded as deferred finance costs.

 

On March 13, 2023, the Company entered into an Amendment to the RSLA (the “Amended RSLA”) whereby, the lender agreed to a limited forbearance on the loan as a result of the existing defaults if the company were to meet certain criteria. As of September 30, 2023, the Company did not meet the criteria as outlined in the Amended RSLA, and therefore the Company was in default on the loan and the lender has the right to demand full repayment of the loan. As a result, the remaining deferred finance cost was amortized to interest expenses and the full amount of the loan is classified as a current liability. In addition, the Lendor will assess a penalty of $450,000 which will be added on the maturity date, but is not currently outstanding. The Company re-negotiated the transaction with the lender and was no longer in default as of December 31, 2023 and as of the date of this Report.

 

As of March 31, 2024 and December 31, 2023, the Company owed a principal amount of $609,788 and $616,932 under this loan, with no remaining unamortized discount, respectively.

 

The Company amortized $17,167 and $7,711 of debt discount and deferred finance costs to interest expense related to notes payable during the three months ended March 31, 2024 and 2023, respectively.

 

Line of Credit 

 

On March 30, 2023, the Company entered into a line of credit agreement with a principal amount of $50,000, which was drawn in full as of March 31, 2024. The line of credit is unsecure, bears interest at 10% and matured on June 30, 2023. The Company paid $1,000 in financing costs associated with the loan. The Company is currently in default of this agreement.

 

The following is an analysis of the annual principal payments require on a fiscal year basis as of March 31, 2024:

 

For the twelve months ended March 31:

 

 

Amount

 

2024

 

$663,551

 

2025

 

 

3,440

 

2026

 

 

3,558

 

2027

 

 

3,727

 

2028

 

 

4,193

 

Thereafter

 

 

121,762

 

Total principal

 

 

800,651

 

 

 
15

Table of Contents

 

Note 6: Convertible Notes Payable and Derivative Liabilities

 

Convertible Notes Payable

 

The following table summarizes outstanding convertible notes as of March 31, 2024 and December 31, 2023:

 

 

 

March 31, 2024

 

 

December 31, 2023

 

 

 

 

 

 

 

 

January 2024 Note, due January 2025

 

$755,334

 

 

 

-

 

June 2019 Notes, due September 30, 2024

 

 

444,444

 

 

$444,444

 

Total principal

 

 

1,199,778

 

 

 

444,444

 

Less: Discounts 

 

 

(51,500 )

 

 

-

 

Total net of discounts

 

 

1,148,278

 

 

 

444,444

 

 

 

 

 

 

 

 

 

 

Less: Current convertible notes payable, net of discount

 

 

(1,148,278 )

 

 

(444,444 )

 

 

 

 

 

 

 

 

 

Total long-term convertible notes payable, net

 

$-

 

 

$-

 

 

On October 20, 2023 the Company entered into an additional amendment with the remaining outstanding note holder of the June 2019 Notes, which resulted in the maturity date of the note being extended to September 30, 2024. As consideration for the note extension, the Company agreed to reset the exercise price of the 1,333,333 warrants held by the note holder to $0.01 per share and reset the conversion price to be the lesser of $0.01 per share or the price per share on a merger closing date. As a result of the price resets, the debt amendment was accounted for as a debt modification. In connection with the agreement, the holder also agreed to exercise 685,713 of the warrants into shares of common stock, which were issued in March 2024. The Company received no cash for the exercise and recognized expense of $6,857. In addition, as a result of the new conversion terms, which are within the control of the Company, the conversion option no longer must be accounted for as a derivative under ASC 815. On the modification date, the conversion option was revalued under the original terms and the resulting fair value was reclassified into equity.

 

On January 5, 2024, the Company and Think Capital Partners, LLC (formerly known as Tysadco Partners, LLC) entered into a Security Purchase Agreement. Think Capital Partners provided the Company with $100,000 in cash and agreed to exchange their 500,000 shares of Series B Convertible Preferred Stock with an original value of $500,000, outstanding dividends of $80,000 and fees of $6,667 into a convertible promissory note with a principal value of $755,333 (the “Exchange”). The convertible promissory note Matures January 3, 2025, bears interest at 12% per year, and had an original issue discount of $68,667. The promissory note and carried interest is convertible into shares of common stock at $0.01 per share. In the event of default on the convertible note, the interest rate increases to 15%. As a result of the Exchange, 500,000 shares of Series B Convertible Preferred Stock. Think Capital Partners also received 3,000,000 shares of common stock with a fair value of $49,500 based on the closing price of the Company’s common stock on January 3, 2024 and 2,000,000 common stock warrants with an exercise price of $0.01 per share and an exercise term of five years. The warrants had an estimate fair value of $27,669 based on a binomial valuation using a term of five years, volatility of 105.63%, a risk free rate of 3.9% and a dividend rate of 0%. The Company determined that the Exchange should be accounted for as an extinguishment of  with the preferred stock holder, with the difference between the carrying value of the Series B Convertible Preferred Stock and the new convertible note being recognized as a dividend of $83,836.

 

The Company amortized $17,167 and $0 of debt discount and deferred finance costs to interest expense related to convertible notes payable during the three months ended March 31, 2024 and 2023, respectively.

 

Accrued interest on notes payable and convertible notes payable was $383,023 and $318,991 as of March 31, 2024 and December 31, 2023, respectively.

 

 
16

Table of Contents

 

Note 7: Equity

 

Common Stock

 

On December 31, 2021, the Board of Directors of the Company and shareholders holding a majority of the voting power of the Company both approved an amendment to the Company’s Article of Incorporation to increase the total number of authorized shares that the Company shall have authority to issue from 100,000,000 shares to 230,000,000 shares, consisting of two classes to be designated respectively, “Common Stock” and “Preferred Stock”, with all such shares having a par value of $0.001 per share, of which 200,000,000 shall be designated as Common stock and 30,000,000 designated as Preferred stock. 

 

As of March 31, 2024 and December 31, 2023, there are 2,777,778 shares remaining to be issued related to 2020 debt conversions of $499,999, which is included in Subscription payable on the consolidated balance sheets.

 

On January 3, 2024, the Company issued 3,000,000 shares of common stock to Think Capital Partners as part of the Exchange as discussed in Note 6.

 

On January 5, 2024, the Company entered into consulting agreements with four consultants to build a new distribution business, Catalyst Distribution. Under the terms of the agreements, the consultants can each earn up to 7,416,667 restricted shares of the Company’s common stock that will be granted over a 12 month period based on attainment of revenue goals. The initial grants are:

 

 

·

David Shin was granted 2,472,222 shares on January 9, 2024.

 

·

Sungchul Sin was granted 2,472,222 shares on January 9, 2024.

 

·

Richard Yoo was granted 2,472,222 shares on January 9, 2024.

 

·

Baron Huber was granted 2,472,222 shares on January 9, 2024.

 

These shares had a fair value of $430,908 based on the closing price of the Company’s common stock at January 5, 2024, which was recognized as stock-based compensation expense.

 

On March 18, 2024, the Company issued 685,713 shares of common stock to the holder of a convertible promissory note related to the October 2023 modification of the note payable and the exercise of those warrants. The Company recognized expense of $6,857 related to this issuance related to the cash not received from the exercise.

 

Series A Redeemable Preferred Stock

 

The Company created the 2,800,000 shares of Series A Preferred Stock out of the 10,000,000 shares of preferred stock authorized by the Company’s articles of incorporation by filing a certificate of designation as authorized by the Company’s board of directors (the “Certificate of Designation”).

 

The Series A Preferred Stock bears a cumulative dividend of 5.0% per annum on the original purchase price and is redeemable by the Company or upon a class vote by the holders of the Series A Preferred Stock at the original purchase price, plus any unpaid dividends then owing, payable in 4 equal quarterly payments. The Series A Preferred Stock converts into the Company’s common stock at a ratio of 2:1, subject to revision on the basis of standard weighted average anti-dilution protective provisions, at the option of the holders of the Series A Preferred Stock or automatically upon the occurrence of a merger, sale of the Company’s assets, or upon another Deemed Liquidation Event as defined in the Certificate of Designation. In the absence of an anti-dilution adjustment, the 2,800,000 shares of Series A Preferred Stock will convert into 1,400,000 shares of the Company’s common stock.

 

The Series A Preferred Stock votes with the Company’s common stock, as a single class, at a rate of 20 votes for each share of Series A Preferred Stock. The Series A Preferred Stock carries a liquidation preference and is participating. The Series A Preferred Stock carries standard protective provisions that preclude the Company from amending its articles of incorporation, bylaws or the terms of the Certificate of Designation adversely to the holders of the Series A Preferred Stock without their prior approval.

 

 
17

Table of Contents

 

Due to the redemption feature, the Company accounts for the Series A Preferred Stock as temporary equity in accordance with ASC 480. The Series A Preferred Stock is accounted for at redemption value.

 

The Company accrued $3,141 in dividends on the Series A Preferred Stock for the three-months ended March 31, 2024. Total accrued dividends at March 31, 2024 and December 31, 2023 were $35,763 and $32,622, respectively. The redemption value of the Series A Preferred Stock as of March 31, 2024 and December 31, 2023 was $287,763 and $284,622, reflected as temporary equity on the Company’s consolidated balance sheet.

 

Series B Convertible Preferred Stock

 

In February 2022, the Company designated 1,000,000 shares of Series B Convertible Preferred Stock (“Series B”). The Series B has a par value of $0.0001 per share, a stated value of $1 per share and carries a dividend of 8%. The Series B are convertible into shares of common stock at a price of $0.06 per share, and contains an exercise price reset provision in the event of dilutive issuances of common stock or any common stock equivalent by the Company with a price below the exercise price.

 

The Series B holders do not have voting rights on matters other than those related to amending the certificate of incorporation of the Series B, altering voting or other powers of the Series B, or redemption or acquisition of outstanding Series B. For a period of one year following closing of the Series B funding, the Company may not authorize or create any class of stock that is senior to the Series B with respect to dividends, redemption or distribution of assets upon Liquidation. In the event of liquidation of the Company, the Series B holders shall be paid 125% of the Stated value plus 125% of any unpaid dividends.

 

During the year ended December 31, 2022, the Company sold a total of 1,000,000 shares of Series B to two investors for net cash proceeds of $885,000 after closing costs of $115,000 and issued warrants to purchase 4,000,000 shares of common stock at $0.20 per share for a period of five years. The Company also issued 2,670,034 shares of common stock with a fair value of $139,800 to the investors, which were recorded as a cost of capital with no expense recognized. The Company granted to the Investors the piggy-back registration rights.

 

In January 2024, the Company entered into the Exchange agreement as discussed in Note 6. As a result, 500,000 shares of Series B Convertible Preferred Stock and $80,000 of accrued dividends were cancelled and exchanged into a convertible promissory note.

 

The Company accrued $9,973 in dividends on the Series B Preferred Stock for the three months ended March 31, 2024. As of March 31, 2024 and December 31, 2023 there were $89,972 and $160,000, respectively, of outstanding accrued dividends. 

 

Stock Warrants

 

A summary of stock warrant information is as follows:

 

 

 

Aggregate

Number

 

 

Aggregate

Exercise

Price

 

 

Weighted

Average

Exercise

Price

 

 

 

 

 

 

 

 

 

 

 

Outstanding at December 31, 2023

 

 

12,068,576

 

 

$2,088,177

 

 

$0.17

 

Granted

 

 

2,000,000

 

 

 

20,000

 

 

 

0.01

 

Exercised

 

 

(685,713 )

 

 

(6,857 )

 

 

0.01

 

Forfeited and cancelled

 

 

(901,909 )

 

 

(224,844 )

 

 

0.25

 

Outstanding at March 31, 2024

 

 

12,480,954

 

 

$1,876,476

 

 

$0.16

 

Exercisable at March 31, 2024

 

 

12,480,954

 

 

$1,876,476

 

 

$0.16

 

 

 
18

Table of Contents

 

 

The weighted average remaining contractual life is approximately 1.80 years for stock warrants outstanding with $5,825 of intrinsic value of as of March 31, 2024. All of the above warrants were fully vested.

 

Note 8: Related Party

 

Mark Adams, CEO, invested $250,000 in the June 2019 Notes and converted his debt during the year ended December 31, 2020 into shares of common stock of 1,388,885, which have yet to be issued for a conversion value of $277,778. Mark Adams will also receive an additional 154,321 shares of common stock once the shares are issued. The Company’s former VP of sales also invested $100,000 in the June 2019 Notes and converted his debt during the year ended December 31, 2020 into shares of common stock of 555,556, which have yet to be issued for a conversion value of $111,111. The former VP of sales will also receive an additional 61,728 shares of common stock once the shares are issued.

 

Those shares were in subscriptions payable as of March 31, 2024 and December 31, 2023, and presented on the balance sheet.

 

Note 9: Leases, Commitments and Contingencies

 

Leases

 

The Company entered into a lease agreement for office space on February 2, 2022, for a term beginning February 15, 2022 through February 28, 2025. The lease requires payments of $3,267 per month through the lease term, increasing by 4% each year, with an option to renew. The Company recognized an initial right of use asset and lease liability of $105,822, based on the present value of the minimum lease payments. For purposes of calculating operating lease liabilities, lease terms may be deemed to include options to extend the lease when it is reasonably certain that the Company will exercise those options. Some leasing arrangements require variable payments that are dependent on usage, output, or may vary for other reasons, such as insurance and tax payments. The variable lease payments are not presented as part of the initial right-of-use (“ROU”) asset or lease liability. The Company’s lease agreements do not contain any material restrictive covenants.

 

The components of lease cost for operating leases for the three months ended March 31, 2024 and 2023 were as follows:

 

 

 

Three Months Ended

 

 

 

March 31, 2024

 

 

March 31, 2023

 

Operating lease cost

 

$10,054

 

 

$10,054

 

Short-term lease cost

 

 

1,946

 

 

 

1,946

 

Total lease cost

 

$12,000

 

 

$12,000

 

 

The following table summarizes the lease-related assets and liabilities recorded in the consolidated balance sheets at March 31, 2024 and December 31, 2023:

 

Lease Position

 

March 31,

2024

 

 

December 31,

2023

 

Operating Leases

 

 

 

 

 

 

Operating lease right-of-use assets

 

$34,991

 

 

$43,965

 

Right of use liability operating lease current portion

 

$41,524

 

 

$39,255

 

Right of use liability operating lease long term

 

 

-

 

 

 

6,978

 

Total operating lease liabilities

 

$41,524

 

 

$46,233

 

 

 
19

Table of Contents

 

The Company utilizes the incremental borrowing rate in determining the present value of lease payments unless the implicit rate is readily determinable. The Company estimated its incremental borrowing rate to be 10%. The lease has a remaining term of 0.9 years and a weighted average rate of 10%.

 

The following table provides the maturities of lease liabilities at March 31, 2024:

 

 

 

 Operating

 

 

 

 Leases

 

2025

 

$42,393

 

2026

 

 

-

 

2027

 

 

-

 

2028

 

 

-

 

2029 and thereafter

 

 

-

 

Total future undiscounted lease payments

 

 

42,393

 

Less: Interest

 

 

(869 )

Present value of lease liabilities

 

$41,524

 

 

Lawsuit

 

The Company has a pending lawsuit with one of its previous suppliers regarding defected cartridges. The Company is still evaluating the case and determining the impact of the case on the Company and as of the date of this report the amount or range of possible losses is not reasonably estimable.

 

Note 10: Accrued Liabilities – Other

 

Prior to the Merger, China Grand Resorts, Inc. recorded various liabilities that were incurred by former related parties. The current management team is not aware of any written agreements in place governing the terms of the loans nor have they been in contact with the debt holders however recognizes that China Grand Resorts, Inc. previously reported these amounts as liabilities of the Company. In accordance with ASC 405-20-40, the liabilities may only be removed from the Company’s financial statements if they are paid, formally settled or judicially released. Management believes the relevant statute of limitations has passed and that no enforceable legal claim exists in relation to these liabilities of $1,642,269 but does not believe that is sufficient to remove the liability from the financial statements. Management does not intend to remove these liabilities of $1,642,269 from the Company’s financial statements until such time that the liability is formally settled or judicially released in accordance with ASC 405-20-40. Due to the lack of written agreements and other factors noted above, management concluded to no longer accrue interest on these loans.

 

Note 11: Subsequent Events

 

Management has evaluated events through May 16, 2024, the date these financial statements were available for issuance, and noted no events requiring disclosures.

 

 
20

Table of Contents

 

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

 

This Management’s Discussion and Analysis of Financial Condition and Results of Operations include several forward-looking statements that reflect management’s current views with respect to future events and financial performance. You can identify these statements by forward-looking words such as “may”, “will”, “expect”, “anticipate”, “believe”, “estimate” and “continue”, or similar words. Those statements include statements regarding the intent, belief or current expectations of us and members of management team as well as the assumptions on which such statements are based. Prospective investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risk and uncertainties, and that actual results may differ materially from those contemplated by such forward-looking statements.

 

Readers are urged to carefully review and consider the various disclosures made by us in this report and in our other reports filed with the SEC. Important factors currently known to management could cause actual results to differ materially from those in forward-looking statements. We undertake no obligation to update or revise forward-looking statements to reflect changed assumptions, the occurrence of unanticipated events or changes in the future operating results over time. We believe that our assumptions are based upon reasonable data derived from and known about our business and operations. No assurances are made that actual results of operations or the results of our future activities will not differ materially from our assumptions. Factors that could cause differences include, but are not limited to, expected market demand for our products, fluctuations in pricing of our products, and competition.

 

The following discussion provides information that management believes is relevant to an assessment and understanding of our past financial condition and plan of operations. The discussion below should be read in conjunction with the consolidated financial statements and related notes thereto included elsewhere in this report.

 

Overview

 

The Company was originally incorporated in the State of Nevada on September 21, 1989 under the name of Fulton Ventures, Inc. Since incorporated, the Company has engaged in a variety of businesses, but has been inactive since late 2014 through the Merger that closed on September 14, 2018. Since the Merger, the Company has been operated under the control of current management and continued to operate the business of Jacksam Corporation, described herein, as our sole business. Our sole business has been the design, manufacturing and sale of vaporizer cartridge filling machines, capping machines, pre-roll & cone filling machines, and cartridges to customers in the medical and recreational cannabis, hemp, and CBD industries.

 

Components of Statements of Operations

 

Revenue

 

Product revenue consists of sales of 710 Shark filling machines, 710 Captain capping machines, “PreRoll-ER” pre-roll & cone filling machines, cartridges, accessories, warranty, service and freight charges, net of returns, discounts and allowances. Once a sales order is negotiated and received by a sales representative, we generally collect a 50% deposit from the customer. When the product is ready to be shipped, the customer will generally pay the remaining balance. We recognize the revenue when the product leaves the warehouse on the way to the customer.

 

For the filling and capping machines, training is coordinated with the customers in accordance with their availability but generally completed within a week or two of the shipment. Standard warranties are offered at no cost to customers to cover parts for three years, and labor and maintenance are offered for one year for product defects.

 

Cost of Revenue

 

Cost of goods sold represents costs directly related to supplies and materials, machines, freight and delivery, commissions, printing, packaging and other costs.

 

We expect our cost of goods sold per unit to decrease as we continue to scale our operations, improve product designs and work with our third-party suppliers to lower costs.

 

Operating Expenses

 

Sales and Marketing. Sales and marketing expenses include costs associated with our business development efforts with our distributors and partners and costs related to trade shows and other marketing programs. We expense sales and marketing costs as incurred. We expect sales and marketing expenses to increase in future periods as we expand our sales and marketing teams and increase our participation in global trade shows and other marketing programs.

 

General and Administrative. Our general and administrative expenses consist primarily of compensation, benefits, travel and other costs for employees. In addition, general and administrative expenses include third-party consulting, legal, audit, accounting services, and allocations of overhead costs, such as rent, facilities and information technology. We expect general and administrative expenses to increase as our revenue increases.

 

 
21

Table of Contents

 

Results of Operations

 

Comparison for the three-month periods ended March 31, 2024 and 2023: 

 

Revenue

 

Total revenue during the three months ended March 31, 2024 was $295,333 (comprised of machine sales of $70,000 and non-machine sales of $225,333), compared to the three months ended March 31, 2023 that generated sales of $628,425 (comprised of machine sales of $343,000 and non-machine sales of $285,425).

 

Cost of Revenue

 

Total cost of revenue decreased to $196,189 during the three months ended March 31, 2024, compared to the three months ended March 31, 2023 that had a cost of revenue of $405,312.

 

Operating Expenses

 

Operating expenses during the three months ended March 31, 2024 increased to $563,932 (comprised of Salaries of $46,968 and Other Sales, Marketing and General and Administrative (“SG&A”) expenses of $510,107 that included a one-time non-cash $437,765 equity compensation), compared to the three months ended March 31, 2023 that produced $243,623 (comprised of Salaries of $112,887 and Other Sales, Marketing and General and Administrative (“SG&A”) expenses of $130,736).

 

Loss from Operations

 

Total loss from operations was $464,788 during the three months ended March 31, 2024, compared to $20,510 for the three months ended March 31, 2023.

 

Derivative Gain

 

Derivative gain, a non-cash item, was $0 during the three months ended March 31, 2024, due to there was no fair value change of the debt and warrants driven by the stock price change between December 31, 2023 and March 31, 2024, compared to $123,301 during the three months ended March 31, 2023.

 

Interest Expense

 

Interest expense, a non-cash item, decreased to $82,111 during the three months ended March 31, 2024, compared to $47,362 during the three months ended March 31, 2023.

 

Net (Loss) / Income

 

Net loss was $546,899 during the three months ended March 31, 2024, compared to a net income of $55,429 during the three months ended March 31, 2023.

 

Liquidity and Capital Resources

 

At March 31, 2024, we had cash and cash equivalents of $104,425. During the three months ended March 31, 2024, we have financed our operations principally through receipts of customer payments and proceeds on the convertible note payable of $100,000.

 

We anticipate that we will need additional financing to continue as an ongoing entity over the next 12 months. Our future capital requirements and the adequacy of available funds will depend on many factors. There can be no assurance we will be able to obtain additional financing on favorable terms, or at all. If we are unable to obtain additional financing, our financial results and business prospects may be materially adversely affected.

 

 
22

Table of Contents

 

Operating Activities

 

We have historically experienced negative cash outflows. Our net cash used in operating activities primarily results from our operating losses combined with changes in working capital components as we have grown our business and is influenced by the timing of cash payments for inventory purchases and cash receipts from our customers. Our primary source of cash flow from operating activities is cash down payments and final payments for our machines. Our primary uses of cash from operating activities are employee-related expenditures and amounts due to vendors for purchased components. Our cash flows from operating activities will continue to be affected principally by our working capital requirements and the extent to which we build up our inventory balances and increase spending on personnel and other operating activities as our business grows.

 

During the three months ended March 31, 2024, net cash used in operating activities was $133,843, compared to $275,037 during the three months ended March 31, 2023.

 

Investing Activities

 

The Company had no investing activities in either period.

 

Financing Activities

 

During the three months ended March 31, 2024, the Company received $100,000 in proceeds from the new convertible note payable, and made payments of $7,253 of convertible notes payable.

 

During the three months ended March 31, 2023, the Company received $50,000 in proceeds from the new line of credit, and made payments of $62,022 of convertible notes payable and $1,000 of debt issuance cost.

 

Off-Balance Sheet Arrangements

 

During the three months ended March 31, 2024 and the year ended December 31, 2023, we did not have any off-balance sheet arrangements as defined by applicable SEC regulations.

 

Item 3. Quantitative and Qualitative Disclosure About Market Risk

 

We do not use derivative financial instruments in our investment portfolio and have no foreign exchange contracts. Our financial instruments consist of cash and cash equivalents. We consider investments that, when purchased, have a remaining maturity of ninety (90) days or less to be cash equivalents. We do not believe that a notional or hypothetical 10% change in interest rates would have a material impact on our interest income.

 

Item 4. Controls and Procedures

 

Management’s Evaluation of Disclosure Controls and Procedures

 

Under the supervision and with the participation of our Chief Executive Officer and Chief Financial Officer, after evaluating the effectiveness of our disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) as of the end of the period covered by this Form 10-Q, we have concluded that, based on such evaluation, our disclosure controls and procedures were effective to ensure that information required to be disclosed by us in the reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the SEC’s rules and forms, and is accumulated and communicated to our management, including our principal executive and principal financial officers, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure.

 

 
23

Table of Contents

  

PART II — OTHER INFORMATION

 

Item 1. Legal Proceedings

 

The Company has a pending lawsuit with one of its previous suppliers regarding defected cartridges. The Company is still evaluating the case and determining the impact of the case on the Company and as of the date of this Report the amount or range of possible losses is not reasonably estimable. From time to time, we may become involved in various lawsuits and legal proceedings that arise in the ordinary course of business. However, litigation is subject to inherent uncertainties, and an adverse result in these or other matters may arise from time to time and harm our business.

 

Item 1A. Risk Factors

 

As a “smaller reporting company” as defined by Item 10 of Regulation S-K, the Company is not required to provide this information.

 

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

 

None.

 

Item 3. Defaults Upon Senior Securities

 

Not applicable.

 

Item 4. Mine Safety Disclosures

 

Not applicable.

 

Item 5. Other Information

 

None.

 

 
24

Table of Contents

  

Item 6. Exhibits

 

Exhibit

Number

 

Exhibit Description

 

31.1

 

Certification of the Company’s Principal Executive Officer and Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002, with respect to the registrant’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2024

 

32.1

 

Certification of the Company’s Principal Executive Officer and Principal Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes Oxley Act of 2002

 

101.INS

 

Inline XBRL Instance Document (the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document)

 

 

 

101.SCH

 

Inline XBRL Taxonomy Extension Schema Document

 

 

 

101.CAL

 

Inline XBRL Taxonomy Extension Calculation Linkbase Document

 

 

 

101.DEF

 

Inline XBRL Taxonomy Extension Definition Linkbase Document

 

 

 

101.LAB

 

Inline XBRL Taxonomy Extension Labels Linkbase Document

 

 

 

101.PRE

 

Inline XBRL Taxonomy Extension Presentation Linkbase Document

 

 

 

104

 

Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)

 

 
25

Table of Contents

  

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

 

JACKSAM CORPORATION

 

 

Dated: May 17, 2024

By:

/s/ Mark Adams

 

Mark Adams

 

Chief Executive Officer and interim Chief Financial Officer

 

 
26

 

nullnullv3.24.1.1.u2
Cover - shares
3 Months Ended
Mar. 31, 2024
May 15, 2024
Cover [Abstract]    
Entity Registrant Name Jacksam Corporation  
Entity Central Index Key 0000860543  
Document Type 10-Q  
Amendment Flag false  
Current Fiscal Year End Date --12-31  
Entity Small Business true  
Entity Shell Company false  
Entity Emerging Growth Company true  
Entity Current Reporting Status Yes  
Document Period End Date Mar. 31, 2024  
Entity Filer Category Non-accelerated Filer  
Document Fiscal Period Focus Q1  
Document Fiscal Year Focus 2024  
Entity Ex Transition Period false  
Entity Common Stock Shares Outstanding   94,663,320
Entity File Number 033-33263  
Entity Incorporation State Country Code NV  
Entity Tax Identification Number 46-3566284  
Entity Address Address Line 1 3100 Airway Avenue Suite 138  
Entity Address Address Line 2 Suite 138  
Entity Address City Or Town Costa Mesa  
Entity Address State Or Province CA  
Entity Address Postal Zip Code 92626  
City Area Code 800  
Local Phone Number 605-3580  
Security 12b Title Common Stock, par value $0.001 per share  
Trading Symbol JKSM  
Document Quarterly Report true  
Document Transition Report false  
Entity Interactive Data Current Yes  
v3.24.1.1.u2
Condensed Consolidated Balance Sheets - USD ($)
Mar. 31, 2024
Dec. 31, 2023
Current Assets:    
Cash $ 104,425 $ 145,521
Accounts receivable, net 18,115 9,515
Inventory, net 0 0
Prepaid expenses 0 77,625
Total Current Assets 122,540 232,661
Property and equipment, net 32 128
Right of-use asset - operating lease 34,991 43,965
Total Assets 157,563 276,754
Current Liabilities:    
Accounts payable and accrued expenses 717,359 756,456
Accrued dividends 89,972 160,000
Deferred revenue 826,321 902,485
Convertible notes payable, current portion 1,148,278 444,444
Notes payable, current portion 613,551 619,932
Line of Credit 50,000 50,000
Right of use liability - operating lease, current portion 41,524 39,255
Derivative liability 0 0
Accrued liabilities - other 1,642,269 1,642,269
Subscription payable 499,999 499,999
Total Current Liabilities 5,629,273 5,114,840
Notes payable, net of current portion (net of discount $87,385 and $94,095 respectively) 137,100 137,972
Right of use liability - operating lease 0 6,978
Total Liabilities 5,766,373 5,259,790
Mezzanine equity    
Series A Preferred stock - 2,800,000 authorized, $0.001 par value, 2,800,000 and 0 shares issued and outstanding as of March 31, 2024 and December 31, 2023 287,763 284,622
Stockholders' Deficit:    
Preferred stock value 0 0
Common stock - 200,000,000 authorized, $0.001 par value, 94,663,320 and 81,088,719 shares issued and outstanding as of March 31, 2024 and December 31, 2023, respectively 94,662 81,088
Additional paid-in capital 8,467,090 8,562,630
Accumulated deficit (14,458,375) (13,911,476)
Total Stockholders' Deficit (5,896,573) (5,267,658)
Total Liabilities and Stockholders' Deficit 157,563 276,754
Series B Preferred Stock    
Stockholders' Deficit:    
Preferred stock value $ 50 $ 100
v3.24.1.1.u2
Condensed Consolidated Balance Sheets (Parenthetical) - USD ($)
Mar. 31, 2024
Dec. 31, 2023
Preferred stock, shares authorized 30,000,000 30,000,000
Preferred stock, par value per share $ 0.001 $ 0.001
Preferred stock, shares issued 0 0
Preferred stock, shares outstanding 0 0
Common stock, shares authorized 200,000,000 200,000,000
Common stock, par value per share $ 0.001 $ 0.001
Common stock, shares issued 94,663,320 81,088,719
Common stock, shares outstanding 94,663,320 81,088,719
Notes Payable [Member]    
Notes payable, current portion (net of discount) $ 87,385 $ 94,095
Series B Preferred Stock [Member]    
Preferred stock, shares authorized 1,000,000 1,000,000
Preferred stock, par value per share $ 0.001 $ 0.001
Preferred stock, shares issued 1,000,000 0
Preferred stock, shares outstanding 1,000,000 0
Preferred stock, stated value per share $ 1 $ 1
Series A Preferred Stock [Member]    
Temporary Equity, Shares Authorized 2,800,000 2,800,000
Temporary Equity, par value per share $ 0.001 $ 0.001
Temporary Equity, shares issued 2,800,000 0
TemporaryEquity, shares outstanding 2,800,000 0
v3.24.1.1.u2
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Condensed Consolidated Statements of Operations (Unaudited)    
Sales $ 295,333 $ 628,425
Cost of sales 196,189 405,312
Gross profit 99,144 223,113
Operating expenses    
Salaries and wages (including contractors) 46,968 112,887
Other selling, general and administrative expenses 516,964 130,736
Total operating expenses 563,932 243,623
Income (loss) from operations (464,788) (20,510)
Other income (expense)    
Derivative gain (loss) 0 123,301
Interest expense (82,111) (47,362)
Loss on conversion of notes payable 0 0
Gain on settlement of notes payable 0 0
Total other income (expense) (82,111) 75,939
Net income (loss) (546,899) 55,429
Deemed dividend on preferred exchange (83,836) 0
Preferred stock dividends (13,114) (22,833)
Net income (loss) available to common shareholders $ (643,849) $ 32,596
Net loss per share    
Basic $ (0.01) $ 0.00
Diluted $ (0.01) $ (0.00)
Weighted average shares outstanding    
Basic 93,465,344 81,088,719
Diluted 93,465,344 173,229,460
v3.24.1.1.u2
Condensed Consolidated Statements of Stockholders' Deficit (Unaudited) - USD ($)
Total
Series A Preferred Stock
Common Stock, $0.001 Par Value
Shares Payable
Paid-In Capital
Accumulated Deficit
Series B Preferred Stock
Balance, shares at Dec. 31, 2022   2,800,000 81,088,719       1,000,000
Balance, amount at Dec. 31, 2022 $ (5,119,181) $ 272,022 $ 81,088 $ 0 $ 7,451,916 $ (12,652,285) $ 100
Dividends on Series A and B Preferred Stock (22,833) 3,107 0 0 (22,833) 0 0
Net income 55,429 $ 0 $ 0 0 0 55,429 $ 0
Balance, shares at Mar. 31, 2023   2,800,000 81,088,719       1,000,000
Balance, amount at Mar. 31, 2023 (5,086,585) $ 275,129 $ 81,088 0 7,429,083 (12,596,856) $ 100
Balance, shares at Dec. 31, 2023   2,800,000 81,088,719       1,000,000
Balance, amount at Dec. 31, 2023 (5,267,658) $ 284,622 $ 81,088 0 8,562,630 (13,911,476) $ 100
Dividends on Series A and B Preferred Stock (13,114) 3,141 0 0 (13,114) 0 0
Net income (546,899) $ 0 $ 0 0 0 (546,899) $ 0
Shares issued for compensation, shares     9,888,888        
Shares issued for compensation, amount 430,908   $ 9,888   421,020    
Shares issued for exercise of warrants, shares     685,713        
Shares issued for exercise of warrants, amount 6,857   $ 686   6,171    
Common shares issued and conversion of Preferred B shares in connection with Note payable, shares     3,000,000       (500,000)
Common shares issued and conversion of Preferred B shares in connection with Note payable, amount (422,831)   $ 3,000   (425,781)   $ (50)
Deemed dividend on extinguishment of Preferred B (83,836)       (83,836)    
Balance, shares at Mar. 31, 2024   2,800,000 94,663,320       500,000
Balance, amount at Mar. 31, 2024 $ (5,896,573) $ 287,763 $ 94,662 $ 0 $ 8,467,090 $ (14,458,375) $ 50
v3.24.1.1.u2
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Cash Flows from Operating Activities    
Net income (loss) $ (546,899) $ 55,429
Adjustments to reconcile net income (loss) to net cash used in operating activities:    
Depreciation expense 96 96
Amortization of debt discount 17,167 7,711
Amortization of right-of-use assets 8,974 8,113
Derivative (gain) loss 0 (123,301)
Net change in:    
Accounts receivable (8,600) (673)
Inventory 0 (24,635)
Prepaid expenses 77,625 4,560
Right-of-use liabilities (4,709) (7,992)
Accounts payable and accrued expenses (39,098) 20,931
Deferred revenue (76,164) (215,276)
Net cash used in operating activities (133,843) (275,037)
Cash Flows from Financing Activities    
Proceeds from line of credit 0 50,000
Proceeds from convertible notes payable 100,000 0
Payment of debt issuance costs 0 (1,000)
Payments on notes payable (7,253) (62,022)
Net cash provided by (used in) financing activities 92,747 (13,022)
Net Change in Cash (41,096) (288,059)
Cash, Beginning of Period 145,521 482,908
Cash, End of Period 104,425 194,849
Cash Paid For:    
Income Taxes 0 0
Interest 912 5,946
Non-cash transactions:    
Conversion of Preferred B and accrued dividends into convertible note payable 580,000 0
Deemed dividend on extinguishment of Preferred B 83,836 0
Preferred stock dividends 13,114 22,833
Exercise of warrants $ 686 $ 0
v3.24.1.1.u2
Organization and Nature of Operations
3 Months Ended
Mar. 31, 2024
Organization and Nature of Operations  
Organization and Nature of Operations

Note 1: Organization and Nature of Operations

 

Jacksam Corporation dba Convectium is a technology company focused on developing and commercializing products of vaporizer cartridge filling & capping, pre-roll filling, and other automation systems. The Company’s product line primarily consisted of the 710 Shark cartridge filling machine, the 710 Captain cartridge capping machine, the “PreRoll-ER” pre-roll & cone filling machine, and cartridges. The Company’s customers are primarily businesses operating in jurisdictions that have some form of cannabis legalization. These businesses include medical and recreational dispensaries, large and small-scale processors and growers, multi-state operators, and distributors. The Company utilizes its direct sales force, website, strategic partners’ sales force, independent sales representatives, and a wide range of referral network to sell its products.

 

The Company was incorporated in the State of Nevada on September 21, 1989 under the name of Fulton Ventures, Inc. Since incorporated, the Company has engaged in a variety of businesses, but has been inactive since late 2014 through the Merger that closed on September 14, 2018. Since the Merger, the Company has been operated under the control of current management and continued to operate the business of Jacksam Corporation, described herein, as our sole business.

v3.24.1.1.u2
Significant Accounting Policies
3 Months Ended
Mar. 31, 2024
Significant Accounting Policies  
Significant Accounting Policies

Note 2: Significant Accounting Policies

 

Basis of Preparation

 

The accompanying financial statements of the Company have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) under the accrual basis of accounting. These financial statements are presented in U.S. dollars and are prepared on a historical cost basis, except for certain financial instruments which are carried at fair value. The accompanying unaudited interim consolidated financial statements of the Company have been prepared in accordance with accounting principles generally accepted in the United States of America and should be read in conjunction with the audited consolidated financial statements and notes thereto for the years ended December 31, 2023 in the Form 10-K filed on April 16, 2024. In the opinion of management, all adjustments, consisting of normal recurring adjustments, necessary for a fair presentation of financial position and the results of operations for the interim periods presented have been reflected herein. The results of operations for the interim periods are not necessarily indicative of the results to be expected for the full year. Notes to the consolidated financial statements which would substantially duplicate the disclosures contained in the Form 10-K have been omitted.

 

Principles of Consolidation

 

The accompanying consolidated financial statements include the accounts of Jacksam Corporation and its wholly owned subsidiary. All intercompany transactions and balances are eliminated in consolidation.

 

Use of Estimates

 

The preparation of financial statements is in conformity with U.S. GAAP and requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Such estimates and assumptions impact both assets and liabilities, including but not limited to net realizable value of accounts receivable and inventory, estimated useful lives and potential impairment of property and equipment, estimate of fair value of share-based payments and derivative liabilities, estimates of fair value of warrants issued and recorded as debt discount and estimates of the probability and potential magnitude of contingent liabilities. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate could change in the near term due to one or more future nonconforming events. Accordingly, actual results could differ significantly from estimates.

 

Risks and Uncertainties

 

The Company’s operations are subject to risk and uncertainties including financial, operational, regulatory and other risks including the potential risk of business failure. The Company has experienced, and in the future, expects to continue to experience, variability in its sales and earnings. The factors expected to contribute to this variability include, among others, (i) the uncertainty associated with the commercialization and ultimate success of the product, (ii) competition inherent at large national retail chains where product is expected to be sold, (iii) general economic conditions, and (iv) the related volatility of prices pertaining to the cost of sales.

 

Cash and Cash Equivalents

 

Cash and cash equivalents are carried at cost and consist of cash on hand and demand deposits placed with banks or other financial institutions, and all highly liquid investments with an original maturity of three months or less. Federal Deposit Insurance Corporation (“FDIC”) deposit insurance covers $250,000 per depositor, per FDIC-insured bank, per ownership category. The Company has no amounts in excess of the FDIC limit as of December 31, 2023

 

Accounts Receivable and Allowance for Doubtful Accounts

 

Accounts receivable are recorded at the invoiced amount and do not bear interest. The Company extends unsecured credit to its customers in the ordinary course of business but mitigates the associated risks by performing credit checks and actively pursuing past due accounts. The Company recognizes an allowance for losses on accounts receivable in an amount equal to the estimated probable losses net of recoveries. The allowance is based on an analysis of historical bad debt experience, current receivables aging, and expected future bad debts, as well as an assessment of specific identifiable customer accounts considered at risk or uncollectible. As of March 31, 2024 and December 31, 2023 and 2022, the Company had recorded an allowance for doubtful accounts of $264,659, respectively. The net accounts receivable at March 31, 2024 and December 31, 2023 were $18,815 and $9,515, respectively.

 

Inventory

 

Inventories are stated at the lower of cost, determined on the average cost basis, or net realizable value. Cost principally consists of the purchase price (adjusted for lower of cost or market), customs, duties, and freight. The Company periodically reviews historical sales activity to determine potentially obsolete items and evaluates the impact of any anticipated changes in future demand.

 

The March 31, 2024 and December 31, 2023 inventory consisted entirely of finished goods. The Company will maintain an allowance based on specific inventory items that have shown no activity over a 60-month period. The Company tracks inventory as it is disposed, scrapped or sold at below cost to determine whether additional items on hand should be reduced in value through an allowance method. As of March 31, 2024 and December 31, 2023, the Company’s inventory allowance was estimated at $244,658 and $244,658, respectively.

 

Property and Equipment

 

Property and equipment are measured at cost, less accumulated depreciation, and are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Depreciation of property and equipment is provided utilizing the straight-line method over the estimated useful lives, ranging from 5 to 7 years of the respective assets. Expenditures for maintenance and repairs are charged to expense as incurred. Upon sale or retirement of property and equipment, the related cost and accumulated depreciation are removed from the accounts and any gain or loss is reflected in the statements of operations.

 

Fair Value of Financial Instruments

 

The Company measures assets and liabilities at fair value based on an expected exit price as defined by the authoritative guidance on fair value measurements, which represents the amount that would be received on the sale of an asset or paid to transfer a liability, as the case may be, in an orderly transaction between market participants. As such, fair value may be based on assumptions that market participants would use in pricing an asset or liability. The authoritative guidance on fair value measurements establishes a consistent framework for measuring fair value on either a recurring or nonrecurring basis whereby inputs, used in valuation techniques, are assigned a hierarchical level.

The following are the hierarchical levels of inputs to measure fair value:

 

·

Level 1 – Observable inputs that reflect quoted market prices in active markets for identical assets or liabilities.

 

 

·

Level 2 - Inputs reflect quoted prices for identical assets or liabilities in markets that are not active; Quoted prices for similar assets or liabilities in active markets; Inputs other than quoted prices that are observable for the assets or liabilities; or inputs that are derived principally from or corroborated by observable market data by correlation or other means.

 

 

·

Level 3 – Unobservable inputs reflecting the Company’s assumptions incorporated in valuation techniques used to determine fair value. These assumptions are required to be consistent with market participant assumptions that are reasonably available.

 

The carrying amounts of the Company’s financial assets and liabilities, such as cash, prepaid expenses, other current assets, accounts payable & accrued expenses, certain notes payable and deferred revenue are an approximate of their fair values because of the short maturity of these instruments. The Company’s derivative liabilities recognized at fair value on a recurring basis are a level 3 measurement. See Note 6.

 

Binomial Calculation Model

 

The Company uses a binomial calculator model to determine fair market value of derivative liabilities, warrants and options issued.

 

Preferred Stock Subject to Possible Redemption

 

The Company accounts for its preferred stock subject to possible redemption in accordance with the guidance in Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity”. Preferred stock subject to mandatory redemption (if any) are classified as a liability instrument and are measured at fair value. Conditionally redeemable preferred stock (including preferred stock that feature redemption rights that are either within the control of the holder or subject to the redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, preferred stock is classified as stockholders’ equity.

 

Revenue Recognition

 

The Company derives revenues from the sale of machines and non-machine products (customizable and C-Cell cartridges and accessories). The Company recognizes revenue in accordance with ASC 606. Revenues are recognized when control of the promised goods or services is transferred to the customer in an amount that reflects the consideration the Company expects to be entitled to in exchange for transferring those goods or services.

 

Revenue is recognized based on the following five step model:

 

 

-

Identification of the contract with a customer

 

-

Identification of the performance obligations in the contract

 

-

Determination of the transaction price

 

-

Allocation of the transaction price to the performance obligations in the contract

 

-

Recognition of revenue when, or as, the Company satisfies a performance obligation

 

Performance Obligations

 

Sales of machines and non-machine products are recognized when all the following criteria are satisfied: (i) a contract with an end user exists which has commercial substance; (ii) it is probable the Company will collect the amount charged to the end user; and (iii) the Company has completed its performance obligation whereby the end user has obtained control of the product. A contract with commercial substance exists once the Company receives and accepts a purchase order or once it enters into a contract with an end user. If collectability is not probable, the sale is deferred and not recognized until collection is probable or payment is received. Control of products typically transfers when title and risk of ownership of the product has transferred to the customer. The customer has a 10-day period to inspect the equipment and may return the product if it does not meet the agreed-upon specifications. For contracts with multiple performance obligations, the Company allocates the total transaction price to each performance obligation in an amount based on the estimated relative standalone selling prices of the promised goods or services underlying each performance obligation. The Company uses an observable price to determine the stand-alone selling price for separate performance obligations or a cost plus margin approach when one is not available. Historically, the Company’s contracts have not had multiple performance obligations. The large majority of the Company’s performance obligations are recognized at a point in time related to the sale of machines and non-machine products.

 

Sales, value add, and other taxes collected concurrent with revenue-producing activities are excluded from revenue. Incidental items that are immaterial in the context of the contract are recognized as expense. Payment terms between invoicing and when payment is due is less than one year. As of March 31, 2024 and December 31, 2023, none of the Company’s contracts contained a significant financing component.

 

The Company elected the practical expedient to not adjust the amount of revenue to be recognized under a contract with an end user for the effects of time value of money when the timing difference between receipt of payment and recognition of revenue is less than one year.

 

The majority of the Company’s contracts offer an assurance-type warranty of the products at no additional cost for a period of 3 years. Assurance-type warranties provide a customer with assurance that the related product will function as the parties intended because it complies with agreed-upon specifications. Such warranties do not represent a separate performance obligation. At the time a sale is recognized, the Company estimated future warranty costs, which were trivial.

 

Transaction Price Allocated to the Remaining Performance Obligations

 

At a given point in time, the Company may have collected payment for future sales of product to begin production. These transactions are deferred until the product transfers to the customer and the performance obligation is considered complete. As of March 31, 2024, $826,321 in revenue is expected to be recognized in the future related to performance obligations that are unsatisfied (or partially unsatisfied) at the end of the reporting period. The Company expects to recognize all of our unsatisfied (or partially unsatisfied) performance obligations as revenue in the next twelve months.

 

Contract Costs

 

Costs incurred to obtain a customer contract are not material to the Company. The Company elected to apply the practical expedient to not capitalize contract costs to obtain contracts with a duration of one year or less, which are expensed and included within cost of goods and services.

 

Critical Accounting Estimates

 

Estimates are used to determine the amount of any variable consideration in contracts and the standalone selling price among separate performance obligations. The Company reviews and updates these estimates regularly.

 

Disaggregation of Revenue

 

All machine sales and most non-machine sales are completed in North America.

 

 

 

Three Months Ended

March 31, 2024

 

 

Three Months Ended

March 31, 2023

 

Machine sales

 

$70,000

 

 

$343,000

 

Non-Machine sales

 

 

225,333

 

 

 

285,425

 

Total sales

 

$295,333

 

 

$628,425

 

 

Net Loss Per Common Share

 

Basic net loss per common share is computed by dividing net loss by the weighted-average number of common shares outstanding during the period. Potential common stock equivalents are determined using the treasury stock method. For diluted net loss per share purposes, the Company excludes stock options and other stock-based awards, including shares issued as a result of option exercises that are subject to repurchase by the Company, whose effect would be anti-dilutive from the calculation.

 

The following table presents the effect of potential dilutive issuances for the three months ended March 31, 2024 and 2023:

 

 

 

Three Months Ended

 

 

 

March 31,

2024

 

 

March 31,

2023

 

 

 

 

 

 

 

 

Net income (loss) attributable to common stockholders

 

$(643,849 )

 

$32,596

 

Preferred stock dividends

 

 

13,144

 

 

 

22,833

 

Derivative gain

 

 

-

 

 

 

(123,301 )

Deemed dividend on preferred exchange

 

 

83,836

 

 

 

-

 

Interest expense associated with convertible debt

 

 

80,773

 

 

 

-

 

Net income (loss) for dilutive calculation

 

 

(466,126 )

 

 

(67,872 )

 

 

 

 

 

 

 

 

 

Weighted average shares outstanding

 

 

93,465,344

 

 

 

8,108,819

 

Dilutive effect of preferred stock

 

 

9,733,333

 

 

 

18,066,667

 

Dilutive effect of convertible debt

 

 

119,977,814

 

 

 

74,074,074

 

Dilutive effect of common stock warrants

 

 

250,945

 

 

 

-

 

Weighted average shares outstanding for diluted net income (loss) per share

 

 

223,427,436

 

 

 

173,229,460

 

 

During the three months ended March 31, 2024, the impact of the 12,480,954 outstanding warrants to purchase common stock, 119,977,814 shares issuable under convertible debt and 9,733,333 shares issuable under convertible preferred stock were excluded from the calculation above as their impact would be anti-dilutive. The calculation for each period presented also excludes 2,777,778 shares not yet issued related to conversions of debt that occurred in 2020.

 

Income Tax Provision

 

The Company accounts for income taxes under Section 740-10-30 of the FASB Accounting Standards Codification, which requires recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the financial statements or tax returns. Under this method, deferred tax assets and liabilities are based on the differences between the financial statement and tax bases of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to reverse. Deferred tax assets are reduced by a valuation allowance to the extent management concludes it is more likely than not that the assets will not be realized. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in the Statements of Operations in the period that includes the enactment date.

ASC 740 prescribes a comprehensive model for how companies should recognize, measure, present, and disclose in their financial statements uncertain tax positions taken or expected to be taken on a tax return. Under ASC 740, tax positions must initially be recognized in the financial statements when it is more likely than not the position will be sustained upon examination by the tax authorities. Such tax positions must initially and subsequently be measured as the largest amount of tax benefit that has a greater than 50% likelihood of being realized upon ultimate settlement with the tax authority assuming full knowledge of the position and relevant facts.

 

The Company recognizes interest and penalties related to unrecognized tax benefits within income tax expense. Accrued interest and penalties are included within the related tax liability.

 

Going Concern

 

The Company’s financial statements are prepared using U.S. GAAP to a going concern, which contemplates the realization of assets and liquidation of liabilities in the normal course of business. However, the Company has negative working capital, recurring losses, and does not have a source of revenues sufficient to cover its operating costs. These factors raise substantial doubt about the Company’s ability to continue as a going concern.

 

The ability of the Company to continue as a going concern is dependent upon its ability to successfully execute the business plan and attain profitable operations. The accompanying financial statements do not include any adjustments that may be necessary if the Company is unable to continue as a going concern.

 

In the coming year, the Company’s foreseeable cash requirements will relate to continual development of the operations of its business, maintaining its good standing and making the requisite filings with the SEC, and the payment of expenses associated with operations and business developments. The Company may experience a cash shortfall and be required to raise additional capital.

 

Historically, it has mostly relied upon convertible notes payable and cash flows from operations to finance its operations and growth. Management may raise additional capital by retaining net earnings or through future private offerings of the Company’s stock or through loans from private investors, although there can be no assurance that it will be able to obtain such financing. The Company’s failure to do so could have a material and adverse effect upon it and its shareholders.

 

Advertising and Marketing Expenses

 

The Company expenses the cost of advertising and promotions as incurred. Advertising and promotions expense was $0 and $220 for the three months ended March 31, 2024 and 2023, respectively.

 

Research and Development Costs

 

Research and development costs are expensed as incurred. The Company incurred no research and development costs during the three months ended March 31, 2024 and 2023.

 

Lease Arrangements

 

The Company follows the guidance of ASC 842 for accounting for leases. Transactions give rise to leases when the Company receives substantially all the economic benefits from and has the ability to direct the use of specified property and equipment. The Company determines if an arrangement is a lease at inception. The operating lease ROU assets are included within the Company’s non-current assets and lease liabilities are included in current or non-current liabilities on the Company’s consolidated balance sheets.

 

ROU assets represent the Company’s right to use, or control the use of, a specified asset for the lease term. Lease liabilities are the Company’s obligation to make lease payments arising from a lease and are measured on a discounted basis. Operating lease ROU assets and operating lease liabilities are recognized based on the present value of the future minimum lease payments over the lease term on the commencement date. The operating lease ROU asset includes any lease payments made and initial direct costs incurred and excludes lease incentives. The lease terms may include options to extend or terminate the lease when it is reasonably certain that the Company will exercise that option. Lease expense for minimum lease payments continues to be recognized on a straight-line basis over the lease term.

 

Recently Issued Accounting Pronouncements

 

From time to time, new accounting pronouncements are issued by the Financial Accounting Standards Board (“FASB”) or other standard setting bodies that are adopted by the Company as of the specified effective date. Unless otherwise discussed, the Company believes that the effect of recently issued standards that are not yet effective and will not have a material effect on its consolidated financial position or results of operations upon adoption.

v3.24.1.1.u2
Property and Equipment
3 Months Ended
Mar. 31, 2024
Property and Equipment  
Property and Equipment

Note 3: Property and Equipment

 

Property and equipment consist of the following:

 

 

 

March 31,

2024

 

 

December 31,

2023

 

 

 

 

 

 

 

 

Furniture and fixtures

 

$10,425

 

 

$10,425

 

Equipment

 

 

7,579

 

 

 

7,579

 

Trade show display

 

 

2,640

 

 

 

2,640

 

Total

 

 

20,644

 

 

 

20,644

 

Less: Accumulated depreciation

 

 

(20,612 )

 

 

(20,516 )

Property and equipment, net

 

$32

 

 

$128

 

 

Depreciation expense amounted to $96 for the three months ended March 31, 2024 and 2023, respectively.

v3.24.1.1.u2
Accounts Payable and Accrued Expenses
3 Months Ended
Mar. 31, 2024
Accounts Payable and Accrued Expenses  
Accounts Payable and Accrued Expenses

Note 4: Accounts Payable and Accrued Expenses

 

Accounts payable and accrued expenses consist of the following:

 

 

 

March 31,

2024

 

 

December 31,

2023

 

 

 

 

 

 

 

 

Accounts payable

 

$189,783

 

 

$292,912

 

Accrued interest

 

 

383,023

 

 

 

318,991

 

Sales tax payable

 

 

144,553

 

 

 

144,553

 

Total Accounts payable and Accrued expenses

 

$717,359

 

 

$756,456

 

v3.24.1.1.u2
Notes Payable and Line of Credit
3 Months Ended
Mar. 31, 2024
Notes Payable and Line of Credit  
Notes Payable and Line of Credit

Note 5: Notes Payable and Line of Credit

 

A summary of Notes Payable are as follows:

 

 

 

March 31,

2024

 

 

December 31,

2023

 

 

 

 

 

 

 

 

SBA loan May 2020

 

 

140,863

 

 

 

141,412

 

Note payable September 2021

 

 

609,788

 

 

 

616,492

 

 

 

 

 

 

 

 

 

 

Total notes payable

 

 

750,651

 

 

 

757,904

 

Less: discount and deferred finance costs

 

 

-

 

 

 

-

 

Less: current portion

 

 

(613,551 )

 

 

(619,932 )

Long-term portion of notes payable

 

$137,100

 

 

 

137,972

 

 

On June 2, 2020, the Company received $150,000 under the Small Business Administration’s Economic Injury Disaster Loan. The loan bears interest at a fixed rate of 3.75%, and matures on May 26, 2050, payable monthly with payments of $731 beginning twelve months after issuance. The loan gives the Small Business Administration a security interest in all assets of the Company. As of March 31, 2024 and December 31, 2023, the Company owed a principal amount of $140,863 and $141,412 under this loan.

 

On September 29, 2021, the Company entered into a Revenue Loan and Security Agreement with an investor for up to a total amount of $1,000,000. Upon drawing from the facility and continuing thereafter until maturity or earlier prepayment in full, the Company shall pay monthly to the lender an amount equal to the product of (i) all revenue of the Company for the immediately preceding month multiplied by (ii) an applicable revenue percentage. On September 29, 2021, the Company borrowed $750,000 under the agreement and received initial cash proceeds of $727,500. The Company also paid an additional $5,000 in fees to the investor to secure the loan for total deferred financing fees of $27,500. On November 12, 2021, the Company issued a total of 843,750 shares of common stock to a lender in connection with the note payable issued. These shares had a fair value of $100,744 and were recorded as deferred finance costs.

 

On March 13, 2023, the Company entered into an Amendment to the RSLA (the “Amended RSLA”) whereby, the lender agreed to a limited forbearance on the loan as a result of the existing defaults if the company were to meet certain criteria. As of September 30, 2023, the Company did not meet the criteria as outlined in the Amended RSLA, and therefore the Company was in default on the loan and the lender has the right to demand full repayment of the loan. As a result, the remaining deferred finance cost was amortized to interest expenses and the full amount of the loan is classified as a current liability. In addition, the Lendor will assess a penalty of $450,000 which will be added on the maturity date, but is not currently outstanding. The Company re-negotiated the transaction with the lender and was no longer in default as of December 31, 2023 and as of the date of this Report.

 

As of March 31, 2024 and December 31, 2023, the Company owed a principal amount of $609,788 and $616,932 under this loan, with no remaining unamortized discount, respectively.

 

The Company amortized $17,167 and $7,711 of debt discount and deferred finance costs to interest expense related to notes payable during the three months ended March 31, 2024 and 2023, respectively.

 

Line of Credit 

 

On March 30, 2023, the Company entered into a line of credit agreement with a principal amount of $50,000, which was drawn in full as of March 31, 2024. The line of credit is unsecure, bears interest at 10% and matured on June 30, 2023. The Company paid $1,000 in financing costs associated with the loan. The Company is currently in default of this agreement.

 

The following is an analysis of the annual principal payments require on a fiscal year basis as of March 31, 2024:

 

For the twelve months ended March 31:

 

 

Amount

 

2024

 

$663,551

 

2025

 

 

3,440

 

2026

 

 

3,558

 

2027

 

 

3,727

 

2028

 

 

4,193

 

Thereafter

 

 

121,762

 

Total principal

 

 

800,651

 

v3.24.1.1.u2
Convertible Notes Payable and Derivative Liabilities
3 Months Ended
Mar. 31, 2024
Convertible Notes Payable and Derivative Liabilities  
Convertible Notes Payable and Derivative Liabilities

Note 6: Convertible Notes Payable and Derivative Liabilities

 

Convertible Notes Payable

 

The following table summarizes outstanding convertible notes as of March 31, 2024 and December 31, 2023:

 

 

 

March 31, 2024

 

 

December 31, 2023

 

 

 

 

 

 

 

 

January 2024 Note, due January 2025

 

$755,334

 

 

 

-

 

June 2019 Notes, due September 30, 2024

 

 

444,444

 

 

$444,444

 

Total principal

 

 

1,199,778

 

 

 

444,444

 

Less: Discounts 

 

 

(51,500 )

 

 

-

 

Total net of discounts

 

 

1,148,278

 

 

 

444,444

 

 

 

 

 

 

 

 

 

 

Less: Current convertible notes payable, net of discount

 

 

(1,148,278 )

 

 

(444,444 )

 

 

 

 

 

 

 

 

 

Total long-term convertible notes payable, net

 

$-

 

 

$-

 

 

On October 20, 2023 the Company entered into an additional amendment with the remaining outstanding note holder of the June 2019 Notes, which resulted in the maturity date of the note being extended to September 30, 2024. As consideration for the note extension, the Company agreed to reset the exercise price of the 1,333,333 warrants held by the note holder to $0.01 per share and reset the conversion price to be the lesser of $0.01 per share or the price per share on a merger closing date. As a result of the price resets, the debt amendment was accounted for as a debt modification. In connection with the agreement, the holder also agreed to exercise 685,713 of the warrants into shares of common stock, which were issued in March 2024. The Company received no cash for the exercise and recognized expense of $6,857. In addition, as a result of the new conversion terms, which are within the control of the Company, the conversion option no longer must be accounted for as a derivative under ASC 815. On the modification date, the conversion option was revalued under the original terms and the resulting fair value was reclassified into equity.

 

On January 5, 2024, the Company and Think Capital Partners, LLC (formerly known as Tysadco Partners, LLC) entered into a Security Purchase Agreement. Think Capital Partners provided the Company with $100,000 in cash and agreed to exchange their 500,000 shares of Series B Convertible Preferred Stock with an original value of $500,000, outstanding dividends of $80,000 and fees of $6,667 into a convertible promissory note with a principal value of $755,333 (the “Exchange”). The convertible promissory note Matures January 3, 2025, bears interest at 12% per year, and had an original issue discount of $68,667. The promissory note and carried interest is convertible into shares of common stock at $0.01 per share. In the event of default on the convertible note, the interest rate increases to 15%. As a result of the Exchange, 500,000 shares of Series B Convertible Preferred Stock. Think Capital Partners also received 3,000,000 shares of common stock with a fair value of $49,500 based on the closing price of the Company’s common stock on January 3, 2024 and 2,000,000 common stock warrants with an exercise price of $0.01 per share and an exercise term of five years. The warrants had an estimate fair value of $27,669 based on a binomial valuation using a term of five years, volatility of 105.63%, a risk free rate of 3.9% and a dividend rate of 0%. The Company determined that the Exchange should be accounted for as an extinguishment of  with the preferred stock holder, with the difference between the carrying value of the Series B Convertible Preferred Stock and the new convertible note being recognized as a dividend of $83,836.

 

The Company amortized $17,167 and $0 of debt discount and deferred finance costs to interest expense related to convertible notes payable during the three months ended March 31, 2024 and 2023, respectively.

 

Accrued interest on notes payable and convertible notes payable was $383,023 and $318,991 as of March 31, 2024 and December 31, 2023, respectively.

v3.24.1.1.u2
Equity
3 Months Ended
Mar. 31, 2024
Equity  
Equity

Note 7: Equity

 

Common Stock

 

On December 31, 2021, the Board of Directors of the Company and shareholders holding a majority of the voting power of the Company both approved an amendment to the Company’s Article of Incorporation to increase the total number of authorized shares that the Company shall have authority to issue from 100,000,000 shares to 230,000,000 shares, consisting of two classes to be designated respectively, “Common Stock” and “Preferred Stock”, with all such shares having a par value of $0.001 per share, of which 200,000,000 shall be designated as Common stock and 30,000,000 designated as Preferred stock. 

 

As of March 31, 2024 and December 31, 2023, there are 2,777,778 shares remaining to be issued related to 2020 debt conversions of $499,999, which is included in Subscription payable on the consolidated balance sheets.

 

On January 3, 2024, the Company issued 3,000,000 shares of common stock to Think Capital Partners as part of the Exchange as discussed in Note 6.

 

On January 5, 2024, the Company entered into consulting agreements with four consultants to build a new distribution business, Catalyst Distribution. Under the terms of the agreements, the consultants can each earn up to 7,416,667 restricted shares of the Company’s common stock that will be granted over a 12 month period based on attainment of revenue goals. The initial grants are:

 

 

·

David Shin was granted 2,472,222 shares on January 9, 2024.

 

·

Sungchul Sin was granted 2,472,222 shares on January 9, 2024.

 

·

Richard Yoo was granted 2,472,222 shares on January 9, 2024.

 

·

Baron Huber was granted 2,472,222 shares on January 9, 2024.

 

These shares had a fair value of $430,908 based on the closing price of the Company’s common stock at January 5, 2024, which was recognized as stock-based compensation expense.

 

On March 18, 2024, the Company issued 685,713 shares of common stock to the holder of a convertible promissory note related to the October 2023 modification of the note payable and the exercise of those warrants. The Company recognized expense of $6,857 related to this issuance related to the cash not received from the exercise.

 

Series A Redeemable Preferred Stock

 

The Company created the 2,800,000 shares of Series A Preferred Stock out of the 10,000,000 shares of preferred stock authorized by the Company’s articles of incorporation by filing a certificate of designation as authorized by the Company’s board of directors (the “Certificate of Designation”).

 

The Series A Preferred Stock bears a cumulative dividend of 5.0% per annum on the original purchase price and is redeemable by the Company or upon a class vote by the holders of the Series A Preferred Stock at the original purchase price, plus any unpaid dividends then owing, payable in 4 equal quarterly payments. The Series A Preferred Stock converts into the Company’s common stock at a ratio of 2:1, subject to revision on the basis of standard weighted average anti-dilution protective provisions, at the option of the holders of the Series A Preferred Stock or automatically upon the occurrence of a merger, sale of the Company’s assets, or upon another Deemed Liquidation Event as defined in the Certificate of Designation. In the absence of an anti-dilution adjustment, the 2,800,000 shares of Series A Preferred Stock will convert into 1,400,000 shares of the Company’s common stock.

 

The Series A Preferred Stock votes with the Company’s common stock, as a single class, at a rate of 20 votes for each share of Series A Preferred Stock. The Series A Preferred Stock carries a liquidation preference and is participating. The Series A Preferred Stock carries standard protective provisions that preclude the Company from amending its articles of incorporation, bylaws or the terms of the Certificate of Designation adversely to the holders of the Series A Preferred Stock without their prior approval.

Due to the redemption feature, the Company accounts for the Series A Preferred Stock as temporary equity in accordance with ASC 480. The Series A Preferred Stock is accounted for at redemption value.

 

The Company accrued $3,141 in dividends on the Series A Preferred Stock for the three-months ended March 31, 2024. Total accrued dividends at March 31, 2024 and December 31, 2023 were $35,763 and $32,622, respectively. The redemption value of the Series A Preferred Stock as of March 31, 2024 and December 31, 2023 was $287,763 and $284,622, reflected as temporary equity on the Company’s consolidated balance sheet.

 

Series B Convertible Preferred Stock

 

In February 2022, the Company designated 1,000,000 shares of Series B Convertible Preferred Stock (“Series B”). The Series B has a par value of $0.0001 per share, a stated value of $1 per share and carries a dividend of 8%. The Series B are convertible into shares of common stock at a price of $0.06 per share, and contains an exercise price reset provision in the event of dilutive issuances of common stock or any common stock equivalent by the Company with a price below the exercise price.

 

The Series B holders do not have voting rights on matters other than those related to amending the certificate of incorporation of the Series B, altering voting or other powers of the Series B, or redemption or acquisition of outstanding Series B. For a period of one year following closing of the Series B funding, the Company may not authorize or create any class of stock that is senior to the Series B with respect to dividends, redemption or distribution of assets upon Liquidation. In the event of liquidation of the Company, the Series B holders shall be paid 125% of the Stated value plus 125% of any unpaid dividends.

 

During the year ended December 31, 2022, the Company sold a total of 1,000,000 shares of Series B to two investors for net cash proceeds of $885,000 after closing costs of $115,000 and issued warrants to purchase 4,000,000 shares of common stock at $0.20 per share for a period of five years. The Company also issued 2,670,034 shares of common stock with a fair value of $139,800 to the investors, which were recorded as a cost of capital with no expense recognized. The Company granted to the Investors the piggy-back registration rights.

 

In January 2024, the Company entered into the Exchange agreement as discussed in Note 6. As a result, 500,000 shares of Series B Convertible Preferred Stock and $80,000 of accrued dividends were cancelled and exchanged into a convertible promissory note.

 

The Company accrued $9,973 in dividends on the Series B Preferred Stock for the three months ended March 31, 2024. As of March 31, 2024 and December 31, 2023 there were $89,972 and $160,000, respectively, of outstanding accrued dividends. 

 

Stock Warrants

 

A summary of stock warrant information is as follows:

 

 

 

Aggregate

Number

 

 

Aggregate

Exercise

Price

 

 

Weighted

Average

Exercise

Price

 

 

 

 

 

 

 

 

 

 

 

Outstanding at December 31, 2023

 

 

12,068,576

 

 

$2,088,177

 

 

$0.17

 

Granted

 

 

2,000,000

 

 

 

20,000

 

 

 

0.01

 

Exercised

 

 

(685,713 )

 

 

(6,857 )

 

 

0.01

 

Forfeited and cancelled

 

 

(901,909 )

 

 

(224,844 )

 

 

0.25

 

Outstanding at March 31, 2024

 

 

12,480,954

 

 

$1,876,476

 

 

$0.16

 

Exercisable at March 31, 2024

 

 

12,480,954

 

 

$1,876,476

 

 

$0.16

 

 

The weighted average remaining contractual life is approximately 1.80 years for stock warrants outstanding with $5,825 of intrinsic value of as of March 31, 2024. All of the above warrants were fully vested.

v3.24.1.1.u2
Related Party
3 Months Ended
Mar. 31, 2024
Related Party  
Related Party

Note 8: Related Party

 

Mark Adams, CEO, invested $250,000 in the June 2019 Notes and converted his debt during the year ended December 31, 2020 into shares of common stock of 1,388,885, which have yet to be issued for a conversion value of $277,778. Mark Adams will also receive an additional 154,321 shares of common stock once the shares are issued. The Company’s former VP of sales also invested $100,000 in the June 2019 Notes and converted his debt during the year ended December 31, 2020 into shares of common stock of 555,556, which have yet to be issued for a conversion value of $111,111. The former VP of sales will also receive an additional 61,728 shares of common stock once the shares are issued.

 

Those shares were in subscriptions payable as of March 31, 2024 and December 31, 2023, and presented on the balance sheet.

v3.24.1.1.u2
Leases Commitments and Contingencies
3 Months Ended
Mar. 31, 2024
Leases Commitments and Contingencies  
Leases, Commitments and Contingencies

Note 9: Leases, Commitments and Contingencies

 

Leases

 

The Company entered into a lease agreement for office space on February 2, 2022, for a term beginning February 15, 2022 through February 28, 2025. The lease requires payments of $3,267 per month through the lease term, increasing by 4% each year, with an option to renew. The Company recognized an initial right of use asset and lease liability of $105,822, based on the present value of the minimum lease payments. For purposes of calculating operating lease liabilities, lease terms may be deemed to include options to extend the lease when it is reasonably certain that the Company will exercise those options. Some leasing arrangements require variable payments that are dependent on usage, output, or may vary for other reasons, such as insurance and tax payments. The variable lease payments are not presented as part of the initial right-of-use (“ROU”) asset or lease liability. The Company’s lease agreements do not contain any material restrictive covenants.

 

The components of lease cost for operating leases for the three months ended March 31, 2024 and 2023 were as follows:

 

 

 

Three Months Ended

 

 

 

March 31, 2024

 

 

March 31, 2023

 

Operating lease cost

 

$10,054

 

 

$10,054

 

Short-term lease cost

 

 

1,946

 

 

 

1,946

 

Total lease cost

 

$12,000

 

 

$12,000

 

 

The following table summarizes the lease-related assets and liabilities recorded in the consolidated balance sheets at March 31, 2024 and December 31, 2023:

 

Lease Position

 

March 31,

2024

 

 

December 31,

2023

 

Operating Leases

 

 

 

 

 

 

Operating lease right-of-use assets

 

$34,991

 

 

$43,965

 

Right of use liability operating lease current portion

 

$41,524

 

 

$39,255

 

Right of use liability operating lease long term

 

 

-

 

 

 

6,978

 

Total operating lease liabilities

 

$41,524

 

 

$46,233

 

The Company utilizes the incremental borrowing rate in determining the present value of lease payments unless the implicit rate is readily determinable. The Company estimated its incremental borrowing rate to be 10%. The lease has a remaining term of 0.9 years and a weighted average rate of 10%.

 

The following table provides the maturities of lease liabilities at March 31, 2024:

 

 

 

 Operating

 

 

 

 Leases

 

2025

 

$42,393

 

2026

 

 

-

 

2027

 

 

-

 

2028

 

 

-

 

2029 and thereafter

 

 

-

 

Total future undiscounted lease payments

 

 

42,393

 

Less: Interest

 

 

(869 )

Present value of lease liabilities

 

$41,524

 

 

Lawsuit

 

The Company has a pending lawsuit with one of its previous suppliers regarding defected cartridges. The Company is still evaluating the case and determining the impact of the case on the Company and as of the date of this report the amount or range of possible losses is not reasonably estimable.

v3.24.1.1.u2
Accrued Liabilities Other
3 Months Ended
Mar. 31, 2024
Accrued Liabilities Other  
Accrued Liabilities - Other

Note 10: Accrued Liabilities – Other

 

Prior to the Merger, China Grand Resorts, Inc. recorded various liabilities that were incurred by former related parties. The current management team is not aware of any written agreements in place governing the terms of the loans nor have they been in contact with the debt holders however recognizes that China Grand Resorts, Inc. previously reported these amounts as liabilities of the Company. In accordance with ASC 405-20-40, the liabilities may only be removed from the Company’s financial statements if they are paid, formally settled or judicially released. Management believes the relevant statute of limitations has passed and that no enforceable legal claim exists in relation to these liabilities of $1,642,269 but does not believe that is sufficient to remove the liability from the financial statements. Management does not intend to remove these liabilities of $1,642,269 from the Company’s financial statements until such time that the liability is formally settled or judicially released in accordance with ASC 405-20-40. Due to the lack of written agreements and other factors noted above, management concluded to no longer accrue interest on these loans.

v3.24.1.1.u2
Subsequent Events
3 Months Ended
Mar. 31, 2024
Subsequent Events  
Subsequent Events

Note 11: Subsequent Events

 

Management has evaluated events through May 16, 2024, the date these financial statements were available for issuance, and noted no events requiring disclosures.

v3.24.1.1.u2
Significant Accounting Policies (Policies)
3 Months Ended
Mar. 31, 2024
Significant Accounting Policies  
Basis of Preparation

The accompanying financial statements of the Company have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) under the accrual basis of accounting. These financial statements are presented in U.S. dollars and are prepared on a historical cost basis, except for certain financial instruments which are carried at fair value. The accompanying unaudited interim consolidated financial statements of the Company have been prepared in accordance with accounting principles generally accepted in the United States of America and should be read in conjunction with the audited consolidated financial statements and notes thereto for the years ended December 31, 2023 in the Form 10-K filed on April 16, 2024. In the opinion of management, all adjustments, consisting of normal recurring adjustments, necessary for a fair presentation of financial position and the results of operations for the interim periods presented have been reflected herein. The results of operations for the interim periods are not necessarily indicative of the results to be expected for the full year. Notes to the consolidated financial statements which would substantially duplicate the disclosures contained in the Form 10-K have been omitted.

Principles of Consolidation

The accompanying consolidated financial statements include the accounts of Jacksam Corporation and its wholly owned subsidiary. All intercompany transactions and balances are eliminated in consolidation.

Use of Estimates

The preparation of financial statements is in conformity with U.S. GAAP and requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Such estimates and assumptions impact both assets and liabilities, including but not limited to net realizable value of accounts receivable and inventory, estimated useful lives and potential impairment of property and equipment, estimate of fair value of share-based payments and derivative liabilities, estimates of fair value of warrants issued and recorded as debt discount and estimates of the probability and potential magnitude of contingent liabilities. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate could change in the near term due to one or more future nonconforming events. Accordingly, actual results could differ significantly from estimates.

Risks and Uncertainties

The Company’s operations are subject to risk and uncertainties including financial, operational, regulatory and other risks including the potential risk of business failure. The Company has experienced, and in the future, expects to continue to experience, variability in its sales and earnings. The factors expected to contribute to this variability include, among others, (i) the uncertainty associated with the commercialization and ultimate success of the product, (ii) competition inherent at large national retail chains where product is expected to be sold, (iii) general economic conditions, and (iv) the related volatility of prices pertaining to the cost of sales.

Cash and Cash Equivalents

Cash and cash equivalents are carried at cost and consist of cash on hand and demand deposits placed with banks or other financial institutions, and all highly liquid investments with an original maturity of three months or less. Federal Deposit Insurance Corporation (“FDIC”) deposit insurance covers $250,000 per depositor, per FDIC-insured bank, per ownership category. The Company has no amounts in excess of the FDIC limit as of December 31, 2023

Accounts Receivable and Allowance for Doubtful Accounts

Accounts receivable are recorded at the invoiced amount and do not bear interest. The Company extends unsecured credit to its customers in the ordinary course of business but mitigates the associated risks by performing credit checks and actively pursuing past due accounts. The Company recognizes an allowance for losses on accounts receivable in an amount equal to the estimated probable losses net of recoveries. The allowance is based on an analysis of historical bad debt experience, current receivables aging, and expected future bad debts, as well as an assessment of specific identifiable customer accounts considered at risk or uncollectible. As of March 31, 2024 and December 31, 2023 and 2022, the Company had recorded an allowance for doubtful accounts of $264,659, respectively. The net accounts receivable at March 31, 2024 and December 31, 2023 were $18,815 and $9,515, respectively.

Inventory

Inventories are stated at the lower of cost, determined on the average cost basis, or net realizable value. Cost principally consists of the purchase price (adjusted for lower of cost or market), customs, duties, and freight. The Company periodically reviews historical sales activity to determine potentially obsolete items and evaluates the impact of any anticipated changes in future demand.

 

The March 31, 2024 and December 31, 2023 inventory consisted entirely of finished goods. The Company will maintain an allowance based on specific inventory items that have shown no activity over a 60-month period. The Company tracks inventory as it is disposed, scrapped or sold at below cost to determine whether additional items on hand should be reduced in value through an allowance method. As of March 31, 2024 and December 31, 2023, the Company’s inventory allowance was estimated at $244,658 and $244,658, respectively.

Property and Equipment

Property and equipment are measured at cost, less accumulated depreciation, and are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Depreciation of property and equipment is provided utilizing the straight-line method over the estimated useful lives, ranging from 5 to 7 years of the respective assets. Expenditures for maintenance and repairs are charged to expense as incurred. Upon sale or retirement of property and equipment, the related cost and accumulated depreciation are removed from the accounts and any gain or loss is reflected in the statements of operations.

Fair Value of Financial Instruments

The Company measures assets and liabilities at fair value based on an expected exit price as defined by the authoritative guidance on fair value measurements, which represents the amount that would be received on the sale of an asset or paid to transfer a liability, as the case may be, in an orderly transaction between market participants. As such, fair value may be based on assumptions that market participants would use in pricing an asset or liability. The authoritative guidance on fair value measurements establishes a consistent framework for measuring fair value on either a recurring or nonrecurring basis whereby inputs, used in valuation techniques, are assigned a hierarchical level.

The following are the hierarchical levels of inputs to measure fair value:

 

·

Level 1 – Observable inputs that reflect quoted market prices in active markets for identical assets or liabilities.

 

 

·

Level 2 - Inputs reflect quoted prices for identical assets or liabilities in markets that are not active; Quoted prices for similar assets or liabilities in active markets; Inputs other than quoted prices that are observable for the assets or liabilities; or inputs that are derived principally from or corroborated by observable market data by correlation or other means.

 

 

·

Level 3 – Unobservable inputs reflecting the Company’s assumptions incorporated in valuation techniques used to determine fair value. These assumptions are required to be consistent with market participant assumptions that are reasonably available.

 

The carrying amounts of the Company’s financial assets and liabilities, such as cash, prepaid expenses, other current assets, accounts payable & accrued expenses, certain notes payable and deferred revenue are an approximate of their fair values because of the short maturity of these instruments. The Company’s derivative liabilities recognized at fair value on a recurring basis are a level 3 measurement. See Note 6.

Binomial Calculation Model

The Company uses a binomial calculator model to determine fair market value of derivative liabilities, warrants and options issued.

Preferred Stock Subject to Possible Redemption

The Company accounts for its preferred stock subject to possible redemption in accordance with the guidance in Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity”. Preferred stock subject to mandatory redemption (if any) are classified as a liability instrument and are measured at fair value. Conditionally redeemable preferred stock (including preferred stock that feature redemption rights that are either within the control of the holder or subject to the redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, preferred stock is classified as stockholders’ equity.

Revenue Recognition

The Company derives revenues from the sale of machines and non-machine products (customizable and C-Cell cartridges and accessories). The Company recognizes revenue in accordance with ASC 606. Revenues are recognized when control of the promised goods or services is transferred to the customer in an amount that reflects the consideration the Company expects to be entitled to in exchange for transferring those goods or services.

 

Revenue is recognized based on the following five step model:

 

 

-

Identification of the contract with a customer

 

-

Identification of the performance obligations in the contract

 

-

Determination of the transaction price

 

-

Allocation of the transaction price to the performance obligations in the contract

 

-

Recognition of revenue when, or as, the Company satisfies a performance obligation

 

Performance Obligations

 

Sales of machines and non-machine products are recognized when all the following criteria are satisfied: (i) a contract with an end user exists which has commercial substance; (ii) it is probable the Company will collect the amount charged to the end user; and (iii) the Company has completed its performance obligation whereby the end user has obtained control of the product. A contract with commercial substance exists once the Company receives and accepts a purchase order or once it enters into a contract with an end user. If collectability is not probable, the sale is deferred and not recognized until collection is probable or payment is received. Control of products typically transfers when title and risk of ownership of the product has transferred to the customer. The customer has a 10-day period to inspect the equipment and may return the product if it does not meet the agreed-upon specifications. For contracts with multiple performance obligations, the Company allocates the total transaction price to each performance obligation in an amount based on the estimated relative standalone selling prices of the promised goods or services underlying each performance obligation. The Company uses an observable price to determine the stand-alone selling price for separate performance obligations or a cost plus margin approach when one is not available. Historically, the Company’s contracts have not had multiple performance obligations. The large majority of the Company’s performance obligations are recognized at a point in time related to the sale of machines and non-machine products.

 

Sales, value add, and other taxes collected concurrent with revenue-producing activities are excluded from revenue. Incidental items that are immaterial in the context of the contract are recognized as expense. Payment terms between invoicing and when payment is due is less than one year. As of March 31, 2024 and December 31, 2023, none of the Company’s contracts contained a significant financing component.

 

The Company elected the practical expedient to not adjust the amount of revenue to be recognized under a contract with an end user for the effects of time value of money when the timing difference between receipt of payment and recognition of revenue is less than one year.

 

The majority of the Company’s contracts offer an assurance-type warranty of the products at no additional cost for a period of 3 years. Assurance-type warranties provide a customer with assurance that the related product will function as the parties intended because it complies with agreed-upon specifications. Such warranties do not represent a separate performance obligation. At the time a sale is recognized, the Company estimated future warranty costs, which were trivial.

 

Transaction Price Allocated to the Remaining Performance Obligations

 

At a given point in time, the Company may have collected payment for future sales of product to begin production. These transactions are deferred until the product transfers to the customer and the performance obligation is considered complete. As of March 31, 2024, $826,321 in revenue is expected to be recognized in the future related to performance obligations that are unsatisfied (or partially unsatisfied) at the end of the reporting period. The Company expects to recognize all of our unsatisfied (or partially unsatisfied) performance obligations as revenue in the next twelve months.

 

Contract Costs

 

Costs incurred to obtain a customer contract are not material to the Company. The Company elected to apply the practical expedient to not capitalize contract costs to obtain contracts with a duration of one year or less, which are expensed and included within cost of goods and services.

 

Critical Accounting Estimates

 

Estimates are used to determine the amount of any variable consideration in contracts and the standalone selling price among separate performance obligations. The Company reviews and updates these estimates regularly.

 

Disaggregation of Revenue

 

All machine sales and most non-machine sales are completed in North America.

 

 

 

Three Months Ended

March 31, 2024

 

 

Three Months Ended

March 31, 2023

 

Machine sales

 

$70,000

 

 

$343,000

 

Non-Machine sales

 

 

225,333

 

 

 

285,425

 

Total sales

 

$295,333

 

 

$628,425

 

Net Loss Per Common Share

Basic net loss per common share is computed by dividing net loss by the weighted-average number of common shares outstanding during the period. Potential common stock equivalents are determined using the treasury stock method. For diluted net loss per share purposes, the Company excludes stock options and other stock-based awards, including shares issued as a result of option exercises that are subject to repurchase by the Company, whose effect would be anti-dilutive from the calculation.

 

The following table presents the effect of potential dilutive issuances for the three months ended March 31, 2024 and 2023:

 

 

 

Three Months Ended

 

 

 

March 31,

2024

 

 

March 31,

2023

 

 

 

 

 

 

 

 

Net income (loss) attributable to common stockholders

 

$(643,849 )

 

$32,596

 

Preferred stock dividends

 

 

13,144

 

 

 

22,833

 

Derivative gain

 

 

-

 

 

 

(123,301 )

Deemed dividend on preferred exchange

 

 

83,836

 

 

 

-

 

Interest expense associated with convertible debt

 

 

80,773

 

 

 

-

 

Net income (loss) for dilutive calculation

 

 

(466,126 )

 

 

(67,872 )

 

 

 

 

 

 

 

 

 

Weighted average shares outstanding

 

 

93,465,344

 

 

 

8,108,819

 

Dilutive effect of preferred stock

 

 

9,733,333

 

 

 

18,066,667

 

Dilutive effect of convertible debt

 

 

119,977,814

 

 

 

74,074,074

 

Dilutive effect of common stock warrants

 

 

250,945

 

 

 

-

 

Weighted average shares outstanding for diluted net income (loss) per share

 

 

223,427,436

 

 

 

173,229,460

 

 

During the three months ended March 31, 2024, the impact of the 12,480,954 outstanding warrants to purchase common stock, 119,977,814 shares issuable under convertible debt and 9,733,333 shares issuable under convertible preferred stock were excluded from the calculation above as their impact would be anti-dilutive. The calculation for each period presented also excludes 2,777,778 shares not yet issued related to conversions of debt that occurred in 2020.

Income Tax Provision

The Company accounts for income taxes under Section 740-10-30 of the FASB Accounting Standards Codification, which requires recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the financial statements or tax returns. Under this method, deferred tax assets and liabilities are based on the differences between the financial statement and tax bases of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to reverse. Deferred tax assets are reduced by a valuation allowance to the extent management concludes it is more likely than not that the assets will not be realized. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in the Statements of Operations in the period that includes the enactment date.

ASC 740 prescribes a comprehensive model for how companies should recognize, measure, present, and disclose in their financial statements uncertain tax positions taken or expected to be taken on a tax return. Under ASC 740, tax positions must initially be recognized in the financial statements when it is more likely than not the position will be sustained upon examination by the tax authorities. Such tax positions must initially and subsequently be measured as the largest amount of tax benefit that has a greater than 50% likelihood of being realized upon ultimate settlement with the tax authority assuming full knowledge of the position and relevant facts.

 

The Company recognizes interest and penalties related to unrecognized tax benefits within income tax expense. Accrued interest and penalties are included within the related tax liability.

Going Concern

The Company’s financial statements are prepared using U.S. GAAP to a going concern, which contemplates the realization of assets and liquidation of liabilities in the normal course of business. However, the Company has negative working capital, recurring losses, and does not have a source of revenues sufficient to cover its operating costs. These factors raise substantial doubt about the Company’s ability to continue as a going concern.

 

The ability of the Company to continue as a going concern is dependent upon its ability to successfully execute the business plan and attain profitable operations. The accompanying financial statements do not include any adjustments that may be necessary if the Company is unable to continue as a going concern.

 

In the coming year, the Company’s foreseeable cash requirements will relate to continual development of the operations of its business, maintaining its good standing and making the requisite filings with the SEC, and the payment of expenses associated with operations and business developments. The Company may experience a cash shortfall and be required to raise additional capital.

 

Historically, it has mostly relied upon convertible notes payable and cash flows from operations to finance its operations and growth. Management may raise additional capital by retaining net earnings or through future private offerings of the Company’s stock or through loans from private investors, although there can be no assurance that it will be able to obtain such financing. The Company’s failure to do so could have a material and adverse effect upon it and its shareholders.

Advertising and Marketing Expenses

The Company expenses the cost of advertising and promotions as incurred. Advertising and promotions expense was $0 and $220 for the three months ended March 31, 2024 and 2023, respectively.

Research and Development Costs

Research and development costs are expensed as incurred. The Company incurred no research and development costs during the three months ended March 31, 2024 and 2023.

Lease arrangements

The Company follows the guidance of ASC 842 for accounting for leases. Transactions give rise to leases when the Company receives substantially all the economic benefits from and has the ability to direct the use of specified property and equipment. The Company determines if an arrangement is a lease at inception. The operating lease ROU assets are included within the Company’s non-current assets and lease liabilities are included in current or non-current liabilities on the Company’s consolidated balance sheets.

 

ROU assets represent the Company’s right to use, or control the use of, a specified asset for the lease term. Lease liabilities are the Company’s obligation to make lease payments arising from a lease and are measured on a discounted basis. Operating lease ROU assets and operating lease liabilities are recognized based on the present value of the future minimum lease payments over the lease term on the commencement date. The operating lease ROU asset includes any lease payments made and initial direct costs incurred and excludes lease incentives. The lease terms may include options to extend or terminate the lease when it is reasonably certain that the Company will exercise that option. Lease expense for minimum lease payments continues to be recognized on a straight-line basis over the lease term.

Recently Issued Accounting Pronouncements

From time to time, new accounting pronouncements are issued by the Financial Accounting Standards Board (“FASB”) or other standard setting bodies that are adopted by the Company as of the specified effective date. Unless otherwise discussed, the Company believes that the effect of recently issued standards that are not yet effective and will not have a material effect on its consolidated financial position or results of operations upon adoption.

v3.24.1.1.u2
Significant Accounting Policies (Tables)
3 Months Ended
Mar. 31, 2024
Significant Accounting Policies  
Schedule of disaggregation of revenue

 

 

Three Months Ended

March 31, 2024

 

 

Three Months Ended

March 31, 2023

 

Machine sales

 

$70,000

 

 

$343,000

 

Non-Machine sales

 

 

225,333

 

 

 

285,425

 

Total sales

 

$295,333

 

 

$628,425

 

Summary of effect of potential dilutive issuances

 

 

Three Months Ended

 

 

 

March 31,

2024

 

 

March 31,

2023

 

 

 

 

 

 

 

 

Net income (loss) attributable to common stockholders

 

$(643,849 )

 

$32,596

 

Preferred stock dividends

 

 

13,144

 

 

 

22,833

 

Derivative gain

 

 

-

 

 

 

(123,301 )

Deemed dividend on preferred exchange

 

 

83,836

 

 

 

-

 

Interest expense associated with convertible debt

 

 

80,773

 

 

 

-

 

Net income (loss) for dilutive calculation

 

 

(466,126 )

 

 

(67,872 )

 

 

 

 

 

 

 

 

 

Weighted average shares outstanding

 

 

93,465,344

 

 

 

8,108,819

 

Dilutive effect of preferred stock

 

 

9,733,333

 

 

 

18,066,667

 

Dilutive effect of convertible debt

 

 

119,977,814

 

 

 

74,074,074

 

Dilutive effect of common stock warrants

 

 

250,945

 

 

 

-

 

Weighted average shares outstanding for diluted net income (loss) per share

 

 

223,427,436

 

 

 

173,229,460

 

v3.24.1.1.u2
Property and Equipment (Tables)
3 Months Ended
Mar. 31, 2024
Property and Equipment  
Schedule of property and equipment

 

 

March 31,

2024

 

 

December 31,

2023

 

 

 

 

 

 

 

 

Furniture and fixtures

 

$10,425

 

 

$10,425

 

Equipment

 

 

7,579

 

 

 

7,579

 

Trade show display

 

 

2,640

 

 

 

2,640

 

Total

 

 

20,644

 

 

 

20,644

 

Less: Accumulated depreciation

 

 

(20,612 )

 

 

(20,516 )

Property and equipment, net

 

$32

 

 

$128

 

v3.24.1.1.u2
Accounts payable and accrued expenses (Tables)
3 Months Ended
Mar. 31, 2024
Accounts Payable and Accrued Expenses  
Schedule of accounts payable and accrued expenses

 

 

March 31,

2024

 

 

December 31,

2023

 

 

 

 

 

 

 

 

Accounts payable

 

$189,783

 

 

$292,912

 

Accrued interest

 

 

383,023

 

 

 

318,991

 

Sales tax payable

 

 

144,553

 

 

 

144,553

 

Total Accounts payable and Accrued expenses

 

$717,359

 

 

$756,456

 

v3.24.1.1.u2
Notes Payable and Line of Credit (Tables)
3 Months Ended
Mar. 31, 2024
Notes Payable and Line of Credit  
Summary of notes payable

 

 

March 31,

2024

 

 

December 31,

2023

 

 

 

 

 

 

 

 

SBA loan May 2020

 

 

140,863

 

 

 

141,412

 

Note payable September 2021

 

 

609,788

 

 

 

616,492

 

 

 

 

 

 

 

 

 

 

Total notes payable

 

 

750,651

 

 

 

757,904

 

Less: discount and deferred finance costs

 

 

-

 

 

 

-

 

Less: current portion

 

 

(613,551 )

 

 

(619,932 )

Long-term portion of notes payable

 

$137,100

 

 

 

137,972

 

Summary of annual principal payments

For the twelve months ended March 31:

 

 

Amount

 

2024

 

$663,551

 

2025

 

 

3,440

 

2026

 

 

3,558

 

2027

 

 

3,727

 

2028

 

 

4,193

 

Thereafter

 

 

121,762

 

Total principal

 

 

800,651

 

v3.24.1.1.u2
Convertible Notes Payable and Derivative Liabilities (Tables)
3 Months Ended
Mar. 31, 2024
Convertible Notes Payable and Derivative Liabilities  
Schedule of outstanding convertible notes

 

 

March 31, 2024

 

 

December 31, 2023

 

 

 

 

 

 

 

 

January 2024 Note, due January 2025

 

$755,334

 

 

 

-

 

June 2019 Notes, due September 30, 2024

 

 

444,444

 

 

$444,444

 

Total principal

 

 

1,199,778

 

 

 

444,444

 

Less: Discounts 

 

 

(51,500 )

 

 

-

 

Total net of discounts

 

 

1,148,278

 

 

 

444,444

 

 

 

 

 

 

 

 

 

 

Less: Current convertible notes payable, net of discount

 

 

(1,148,278 )

 

 

(444,444 )

 

 

 

 

 

 

 

 

 

Total long-term convertible notes payable, net

 

$-

 

 

$-

 

v3.24.1.1.u2
Equity (Tables)
3 Months Ended
Mar. 31, 2024
Equity  
Summary of stock warrant

 

 

Aggregate

Number

 

 

Aggregate

Exercise

Price

 

 

Weighted

Average

Exercise

Price

 

 

 

 

 

 

 

 

 

 

 

Outstanding at December 31, 2023

 

 

12,068,576

 

 

$2,088,177

 

 

$0.17

 

Granted

 

 

2,000,000

 

 

 

20,000

 

 

 

0.01

 

Exercised

 

 

(685,713 )

 

 

(6,857 )

 

 

0.01

 

Forfeited and cancelled

 

 

(901,909 )

 

 

(224,844 )

 

 

0.25

 

Outstanding at March 31, 2024

 

 

12,480,954

 

 

$1,876,476

 

 

$0.16

 

Exercisable at March 31, 2024

 

 

12,480,954

 

 

$1,876,476

 

 

$0.16

 

v3.24.1.1.u2
Leases Commitments and Contingencies (Tables)
3 Months Ended
Mar. 31, 2024
Leases Commitments and Contingencies  
Schedule of operating lease cost

 

 

Three Months Ended

 

 

 

March 31, 2024

 

 

March 31, 2023

 

Operating lease cost

 

$10,054

 

 

$10,054

 

Short-term lease cost

 

 

1,946

 

 

 

1,946

 

Total lease cost

 

$12,000

 

 

$12,000

 

Summary of lease related assets and liabilities

Lease Position

 

March 31,

2024

 

 

December 31,

2023

 

Operating Leases

 

 

 

 

 

 

Operating lease right-of-use assets

 

$34,991

 

 

$43,965

 

Right of use liability operating lease current portion

 

$41,524

 

 

$39,255

 

Right of use liability operating lease long term

 

 

-

 

 

 

6,978

 

Total operating lease liabilities

 

$41,524

 

 

$46,233

 

Schedule of maturities of lease liabilities

 

 

 Operating

 

 

 

 Leases

 

2025

 

$42,393

 

2026

 

 

-

 

2027

 

 

-

 

2028

 

 

-

 

2029 and thereafter

 

 

-

 

Total future undiscounted lease payments

 

 

42,393

 

Less: Interest

 

 

(869 )

Present value of lease liabilities

 

$41,524

 

v3.24.1.1.u2
Significant Accounting Policies (Details) - USD ($)
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Total sales $ 295,333 $ 628,425
North America [Member]    
Machine sales 70,000 343,000
Non-Machine sales 225,333 285,425
Total sales $ 295,333 $ 628,425
v3.24.1.1.u2
Significant Accounting Policies (Details 1) - USD ($)
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Significant Accounting Policies    
Net income (loss) attributable to common stockholders $ (643,849) $ 32,596
Preferred stock dividends 13,144 22,833
Derivative gain 0 (123,301)
Deemed dividend on preferred exchange 83,836 0
Interest expense associated with convertible debt 80,773 0
Net income (loss) for dilutive calculation (466,126) (67,872)
Weighted average shares outstanding 93,465,344 8,108,819
Dilutive effect of preferred stock 9,733,333 18,066,667
Dilutive effect of convertible debt 119,977,814 74,074,074
Dilutive effect of common stock warrants 250,945 0
Weighted average shares outstanding for diluted net income (loss) per share $ 223,427,436 $ 173,229,460
v3.24.1.1.u2
Significant Accounting Policies (Details Narrative) - USD ($)
3 Months Ended 12 Months Ended
Mar. 31, 2024
Dec. 31, 2023
Allowance for Doubtful Accounts $ 264,659 $ 264,659
Inventory allowance 244,658 244,658
Net accounts receivable $ 18,815 9,515
Purchase of Common stock and warrants 12,480,954  
Shares issuable under convertible debt excluded from calculation 2,777,778  
Convertible preferred stock 9,733,333  
FDIC insurance amount   250,000
Deferred revenue $ 826,321 902,485
Advertising and marketing expenses $ 0 $ 220
Issuance of shares under convertible debt 119,977,814  
Minimum [Member]    
Property and equipment , estimated useful lives 5 years  
Maximum [Member]    
Property and equipment , estimated useful lives 7 years  
v3.24.1.1.u2
Property and Equipment (Details) - USD ($)
Mar. 31, 2024
Dec. 31, 2023
Less: Accumulated Depreciation $ (20,612) $ (20,516)
Property and equipment Gross 20,644 20,644
Property and Equipment net 32 128
Furniture and Fixtures [Member]    
Property and equipment Gross 10,425 10,425
Equipments [Member]    
Property and equipment Gross 7,579 7,579
Trade Show Displays [Member]    
Property and equipment Gross $ 2,640 $ 2,640
v3.24.1.1.u2
Property and Equipment (Details Narrative) - USD ($)
3 Months Ended 12 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Dec. 31, 2023
Property and Equipment      
Depreciation expense $ 96 $ 96 $ 96
v3.24.1.1.u2
Accounts Payable and Accrued Expenses (Details) - USD ($)
Mar. 31, 2024
Dec. 31, 2023
Total Accounts payable and Accrued expenses $ 717,359 $ 756,456
Accounts payable [Member]    
Total Accounts payable and Accrued expenses 189,783 292,912
Accrued interest [Member]    
Total Accounts payable and Accrued expenses 383,023 318,991
Sales tax payable [Member]    
Total Accounts payable and Accrued expenses $ 144,553 $ 144,553
v3.24.1.1.u2
Notes Payable and Line of Credit (Details) - USD ($)
Mar. 31, 2024
Dec. 31, 2023
Total notes payable $ 750,651 $ 757,904
Less discount and deferred finance costs 0 0
Less: current portion (613,551) (619,932)
Long term portion of notes payable 137,100 137,972
SBA loan May 2020 [Member]    
Total notes payable 140,863 141,412
Note Payable September 2021 [Member]    
Total notes payable $ 609,788 $ 616,492
v3.24.1.1.u2
Notes Payable and Line of Credit (Details 1)
Mar. 31, 2024
USD ($)
Notes Payable and Line of Credit  
2024 $ 663,551
2025 3,440
2026 3,558
2027 3,727
2028 4,193
Thereafter 121,762
Total principal $ 800,651
v3.24.1.1.u2
Notes Payable and Line of Credit (Details Narrative) - USD ($)
1 Months Ended 3 Months Ended 12 Months Ended
Jun. 02, 2020
Sep. 29, 2021
Mar. 31, 2024
Dec. 31, 2023
Principal amount     $ 50,000  
Amortization of debt discount     $ 17,167 $ 7,711
Common stock issued to a lender     2,670,034  
Deferred finance costs     $ 1,000  
Maturity date     Jun. 30, 2023  
Penalty amount not yet assesed     $ 450,000  
Interest rate     10.00%  
Revenue Loan and Security Agreement [Member]        
Principal amount     $ 609,788 616,932
Investor fees   $ 5,000    
Financing fees   27,500    
Borrowed amount   750,000    
Initial cash proceeds   $ 727,500    
Common stock issued to a lender   843,750    
Deferred finance costs   $ 100,744    
Proceeds from loan   $ 1,000,000    
Payroll Protection Program [Member]        
Principal amount $ 140,863   $ 140,863 $ 141,412
Maturity date May 26, 2050      
Interest rate 3.75%      
Proceeds from loan $ 150,000      
Debt description payments of $731 beginning twelve months after issuance      
v3.24.1.1.u2
Convertible Notes Payable and Derivative Liabilities (Details) - USD ($)
Mar. 31, 2024
Dec. 31, 2023
Total principal $ 1,199,778 $ 444,444
Less: Discounts (51,500) 0
Total net of discounts 1,148,278 444,444
Less: Current convertible notes payable, net of discount (1,148,278) 444,444
Total long-term convertible notes payable, net 0 0
June 2019 Notes, Due September 30, 2024 [Member]    
Total 444,444 444,444
January 2024 Notes, Due January 2025 [Member]    
Total $ 755,334 $ 0
v3.24.1.1.u2
Convertible Notes Payable and Derivative Liabilities (Details Narrative) - USD ($)
1 Months Ended 3 Months Ended 12 Months Ended
Jan. 05, 2024
Oct. 20, 2023
Mar. 31, 2024
Mar. 31, 2023
Dec. 31, 2022
Jan. 03, 2024
Dec. 31, 2023
Accrued interest     $ 383,023       $ 318,991
Amortization of debt discount     $ 17,167 $ 7,711 $ 0    
Convertible Preferred Stockc share 500,000         2,000,000  
Common stock, par value per share     $ 0.001     $ 0.01 $ 0.001
Interest rate     10.00%        
Maturity date     Jun. 30, 2023        
Series B Convertible Preferred Stock [Member]              
Total expense $ 100,000            
Convertible Preferred Stockc share 500,000            
Original value $ 500,000            
Outstanding dividends 80,000            
Outstanding Fee $ 6,667            
Common stock, par value per share $ 0.01            
Common stock 3,000,000            
Principal amount $ 755,333            
Original issue discount 68,667            
Fair value 49,500            
Estimate fair value $ 27,669            
Volatility 105.63%            
Risk-free rate 3.90%            
Dividend Yield 0.00%            
Exercise term 5 years            
Interest rate 12.00%            
Increases interest rate 15.00%            
Maturity date Jan. 03, 2025            
Warrants [Member]              
Warrants held   1,333,333          
Total expense   $ 6,857          
Warrant exercise price   $ 0.01          
Convertible promissory note   685,713          
Dividend $ 83,836            
v3.24.1.1.u2
Equity (Details)
3 Months Ended
Mar. 31, 2024
USD ($)
$ / shares
shares
Aggregate Number  
Aggregate number, Beginning | shares 12,068,576
Granted | shares 2,000,000
Exercised | shares 685,713
Less: forfeited and cancelled | shares (901,909)
Aggregate number, Ending | shares 12,480,954
Aggregate number of stock warrant exercisable | shares 12,480,954
Aggregate Exercise Price  
Aggregate exercise price, Beginning | $ $ 2,088,177
Granted | $ 20,000
Exercised | $ (6,857)
Forfeited and cancelled | $ (224,844)
Aggregate exercise price, Ending | $ 1,876,476
Aggregate exercise price, Exercisable | $ $ 1,876,476
Weighted average exercise price, Beginning | $ / shares $ 0.17
Granted | $ / shares 0.01
Exercised | $ / shares 0.01
Forfeited and cancelled | $ / shares 0.25
Weighted average exercise price, Ending | $ / shares 0.16
Weighted average exercise price, Exercisable | $ / shares $ 0.16
v3.24.1.1.u2
Equity (Details Narrative) - USD ($)
1 Months Ended 3 Months Ended 12 Months Ended
Jan. 09, 2024
Jan. 05, 2024
Jan. 03, 2024
Mar. 18, 2024
Jan. 31, 2024
Mar. 31, 2024
Mar. 31, 2023
Dec. 31, 2022
Dec. 31, 2023
May 26, 2021
Common stock designated           200,000,000        
Preferred stock designated           30,000,000        
Common stock, shares par value     $ 0.01     $ 0.001     $ 0.001  
Common stock shares Issued     $ 3,000,000              
Consulting agreements   the consultants can each earn up to 7,416,667 restricted shares of the Company’s common stock that will be granted over a 12 month period based on attainment of revenue goals                
Common stock issued to investors           2,670,034        
Fair value of common stock           $ 139,800        
Subscriptions payable liability balance                 $ 499,999  
Subscriptions payable liability balance in shares           2,777,778     2,777,778  
Weighted average remaining contractual life           1 year 9 months 18 days        
Accrued dividend           $ 13,114 $ 22,833      
Cancellation of accured dividend         $ 80,000          
Intrinsic value of warrants           $ 5,825        
Convertible promissory note       685,713            
Expense       $ 6,857            
Par value, preferred stock           $ 0.001     $ 0.001  
Stock-based compensation expense   $ 430,908                
Preferred stock values           $ 0     $ 0  
Preferred stock, shares issued           0     0  
Increased the authorized shares           230,000,000     230,000,000  
Authorized shares previously           100,000,000        
David Shin [Member]                    
Shares Granted 2,472,222                  
Sungchul Sin [Member]                    
Shares Granted 2,472,222                  
Richard Yoo [Member]                    
Shares Granted 2,472,222                  
Baron Huber [Member]                    
Shares Granted 2,472,222                  
Mr Mark Adamsand Mr David Hall [Member]                    
Shares issued for subscriptions payable           2,800,000        
Convertible debt converted and stock           1,400,000        
Series A Redeemable Preferred Stock [Member] | Subscription Agreement [Member] | Scott Wessler [Member]                    
Accrued dividend           $ 3,141        
Accrued dividend outstanding           35,763     $ 32,622  
Redemption value           $ 287,763     284,622  
DIvidend percent           5.00%        
Preferred stock, shares issued                   1,400,000
Description           The Company created the 2,800,000 shares of Series A Preferred Stock out of the 10,000,000 shares of preferred stock authorized by the Company’s articles of incorporation by filing a certificate of designation as authorized by the Company’s board of directors (the “Certificate of Designation”).        
Series B                    
Accrued dividend           $ 9,973        
Accrued dividend outstanding           $ 89,972     $ 160,000  
Par value, preferred stock           $ 0.0001        
Warrants to purchase shares of common stock           4,000,000        
Cancellation of preferred stock         500,000          
Designated preferred shares           $ 1,000,000        
Preferred stock,shares stated value           $ 1        
Conversion price           $ 0.06        
DIvidend percent           8.00%        
Net cash proceeds from invester               $ 885,000    
Preferred stock shares sold               1,000,000    
Closing costs               $ 115,000    
Common stock as purchase price           $ 0.20        
v3.24.1.1.u2
Related Party (Details Narrative)
3 Months Ended
Mar. 31, 2024
USD ($)
shares
VP [Member]  
Debt instrument conversion amount to related party | $ $ 100,000
Issued for conversion of common stock, shares | shares 555,556
Additional shares of common stock issued | shares 61,728
Issued for conversion of common stock, value | $ $ 111,111
Mr. Adams [Member]  
Debt instrument conversion amount to related party | $ $ 250,000
Issued for conversion of common stock, shares | shares 1,388,885
Additional shares of common stock issued | shares 154,321
Issued for conversion of common stock, value | $ $ 277,778
v3.24.1.1.u2
Leases Commitments and Contingencies (Details) - USD ($)
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Leases Commitments and Contingencies    
Operating lease cost $ 10,054 $ 10,054
Short-term lease cost 1,946 1,946
Total lease cost $ 12,000 $ 12,000
v3.24.1.1.u2
Leases Commitments and Contingencies (Details 1) - USD ($)
Mar. 31, 2024
Dec. 31, 2023
Leases Commitments and Contingencies    
Operating lease right-of-use assets $ 34,991 $ 43,965
Right of use liability operating lease current portion 41,524 39,255
Right of use liability operating lease long term 0 6,978
Total operating lease liabilities $ 41,524 $ 46,233
v3.24.1.1.u2
Leases Commitments and Contingencies (Details 2)
Mar. 31, 2024
USD ($)
Leases Commitments and Contingencies  
2025 $ 42,393
2026 0
2027 0
2028 0
2029 and thereafter 0
Total future undiscounted lease payments 42,393
Less: Interest (869)
Present value of lease liabilities $ 41,524
v3.24.1.1.u2
Leases Commitments and Contingencies (Details Narrative)
3 Months Ended
Mar. 31, 2024
USD ($)
Leases Commitments and Contingencies  
Lease payments per months $ 3,267
Lease payments increased percentage 4.00%
Right of use asset and lease liability $ 105,822
Incremental borrowing rate, percentage 10.00%
Weighted average incremental rate, percentage 10.00%
Lease remaining term 10 months 24 days
v3.24.1.1.u2
Accrued Liabilities Other (Details Narrative)
Mar. 31, 2024
USD ($)
Accrued Liabilities - other $ 1,642,269
China Grand Resort[Member]  
Accrued Liabilities - other $ 1,642,269

Jacksam (PK) (USOTC:JKSM)
過去 株価チャート
から 10 2024 まで 11 2024 Jacksam (PK)のチャートをもっと見るにはこちらをクリック
Jacksam (PK) (USOTC:JKSM)
過去 株価チャート
から 11 2023 まで 11 2024 Jacksam (PK)のチャートをもっと見るにはこちらをクリック